TWI304810B - Oil body-based purification of proteins - Google Patents

Oil body-based purification of proteins Download PDF

Info

Publication number
TWI304810B
TWI304810B TW94136100A TW94136100A TWI304810B TW I304810 B TWI304810 B TW I304810B TW 94136100 A TW94136100 A TW 94136100A TW 94136100 A TW94136100 A TW 94136100A TW I304810 B TWI304810 B TW I304810B
Authority
TW
Taiwan
Prior art keywords
polypeptide
protein
oil
intein
oil body
Prior art date
Application number
TW94136100A
Other languages
Chinese (zh)
Other versions
TW200716663A (en
Inventor
Chung Jen Chiang
Hung Chen Chen
Yun Peng Chao
Tze Cheng Tzen
Original Assignee
Nat Univ Chung Hsing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Chung Hsing filed Critical Nat Univ Chung Hsing
Priority to TW94136100A priority Critical patent/TWI304810B/en
Publication of TW200716663A publication Critical patent/TW200716663A/en
Application granted granted Critical
Publication of TWI304810B publication Critical patent/TWI304810B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

1304810 七、指定代表圖: (一) 本案指定代表圖為:第(2 )圖。 (二) 本代表圖之元件符號簡單說明:無 八式若雜學式時,請揭^最賴示發珊徵的化學 九、發明說明: 【發明所屬之技術領域】 本發明係關於-種製造蛋白質之方法,該方法藉表現有關蛋白質與結 合油體蛋白質組成雜合分子,純化該雜合分子,然後由雜合分子剩下部 份分離目標蛋白質。 【先前技術】 使用重組核酸系統進行蛋白質的表現與純化是一種有效且廣泛應用的 技術。大體而言,蛋白質純化須經由多重步驟,其產製過程通常也較昂 貴。 純化方式如沉殿法、分子筛色層分析法(m〇lecular也呢 chr_tGgraphy)、電泳、親合性色層分析法(aff ini技chr〇論卿加) 和共&色層分析法(covalent chromatography)係已知技藝且已常用於細 胞萃取物中純化蛋白質。此類純化方法經常需表現目標蛋白質當作一種 融合蛋白質或喪合蛋白質。融合蛋白質技術經常用在蛋白質的純化過程 中提供"標記”或''操作"。 一般而s,這些系統表現的融合蛋白質包含一親合性標記,如穀胱甘 狀S-轉移酶(glutathione S-transferase)、麥芽糖結合蛋白 (脆ltose-binding pr〇tein)、纖維素結合域(cellul〇se_binding © 5 1304810 domain)、聚組胺酸(polyhistidine)、聚半胱胺酸蛋白a (p〇iycysteine, protein A)及鏈黴親合素(streptavidin),且以共價鍵結合於目標蛋白 之N-端或C-端(Smith D.B. and Johnson K.S. 1998 Gene 67: 31-401304810 VII. Designated representative map: (1) The representative representative of the case is: (2). (2) A brief description of the symbol of the representative figure: If there is no eight-style hybrid language, please disclose the chemical that best depends on the hair of the yan. The invention is as follows: [Technical field of the invention] The present invention relates to A method of producing a protein, which comprises purifying the hybrid molecule by expressing a hybrid molecule comprising the protein and the binding oil body protein, and then separating the target protein from the remaining part of the hybrid molecule. [Prior Art] The use of recombinant nucleic acid systems for protein expression and purification is an effective and widely used technique. In general, protein purification requires multiple steps and its production process is often expensive. Purification methods such as sinking method, molecular sieve chromatography (m〇lecular also chr_tGgraphy), electrophoresis, affinity chromatography (aff ini technique chr〇庆庆庆) and common & chromatography (covalent) Chromatography) is a well-known technique and has been commonly used in cell extracts to purify proteins. Such purification methods often require the expression of the target protein as a fusion protein or a nucleus protein. Fusion protein technology is often used to provide "labeling" or "operation" during protein purification. Typically, these systems exhibit fusion proteins that contain an affinity tag, such as glutathione S-transferase ( Glutathione S-transferase), maltose binding protein (brittle-binding pr〇tein), cellulose binding domain (cellul〇se_binding © 5 1304810 domain), polyhistidine (polyhistidine), polycysteine protein a (p 〇iycysteine, protein A) and streptavidin, and covalently bind to the N-terminus or C-terminus of the target protein (Smith DB and Johnson KS 1998 Gene 67: 31-40

Sakhamuru K., et al. 2000. Biotechnol Prog 16: 296-298 , Mateo C et al. 2001. J Chromatogr A 915: 97-106.)。為利於親合性純化,對 此標記具專一性之配體(ligand)通常被固定於一佈於管柱的固態相上。 結合至親合性管柱之後,高純度之融合蛋白質則藉由加入過量之配體或 調整緩衝液pH值而沖提出。目標蛋白質從標記分子上之分離係在通入管 柱或沖提後,以限定量的蛋白水解酶切割於其接合子序列 (Schauer-Vukasionovic V., et al. 2002. Anal. Bioanal. Chem. 373: 501-507.)。其中所用親合性管柱之準備與操作上,雖簡易但價格昂責。 例如,美國專利第4782137號揭露一抗體固定式 (antibody-immobolized)免疫親合技術,結合一種表現的融合蛋白,包 含一具抗原性之寡肽標記,該標記有一"抗原性前端"("antigenichead„) 部分及一"連接尾端"("linking tail")部分。該抗原性部分組成係為一 些可迅速引發抗原性反應之親水性胺基酸。而連接部分則允許該標記在 融合蛋白質從細胞分離後,由所需蛋白質上被切割分離。 其他牽涉表現及純化技術的方法結合使用酵素性標記如穀胱甘肽轉移 酶(glutathione transferase)、沒-半乳糖苷酶(beta_galact〇sidase) 及氯黴素乙醯轉移酶(chloramphenicol acetyl transferase),這些標 記可與適當受質結合。詳見Smith D. B.等,Gene,67, 31-40 (1988)。 在這些例子中,作為標記的酶係與目標蛋白質融合,使該融合產物結合 於一固定受質上,再以生化方法將該標記酶從所需蛋白質上切除。以上 所有實例之施行皆須特殊管柱及昂貴之試劑。 6 d 1304810 植物種子油體是萌芽和爾後幼株成長所需燃料的貯藏胞器(此 A.H.C. 1996. Plant Physiol. Π〇: 1055-1061., Peng C. C. and Tzen " J.C.T. 1998. Plant Cell Physiol. 39: 35-42., Frandsen G. I., 2001.Sakhamuru K., et al. 2000. Biotechnol Prog 16: 296-298, Mateo C et al. 2001. J Chromatogr A 915: 97-106.). To facilitate affinity purification, a ligand specific to this label is typically immobilized on a solid phase of the column. After binding to the affinity column, the high purity fusion protein is flushed by adding excess ligand or adjusting the pH of the buffer. The separation of the target protein from the labeling molecule is followed by a defined amount of proteolytic enzyme cleavage into its zygote sequence after introduction into the column or extraction (Schauer-Vukasionovic V., et al. 2002. Anal. Bioanal. Chem. 373 : 501-507.). The preparation and operation of the affinity column used therein is simple but expensive. For example, U.S. Patent No. 4,782,137 discloses an antibody-immobolized immunoaffinity technique that incorporates an expression of a fusion protein comprising an antigenic oligopeptide tag having an "antigenic front end""antigenichead„) part and a "linking tail"("linkingtail") part of the antigenic part of the composition of the hydrophilic amino acid can quickly initiate an antigenic reaction. The marker is cleaved from the desired protein after the fusion protein is isolated from the cell. Other methods involving performance and purification techniques use an enzyme marker such as glutathione transferase, galactosidase (beta_galact〇sidase) and chloramphenicol acetyl transferase, these markers can be combined with appropriate substrates. See Smith DB et al, Gene, 67, 31-40 (1988) for details. The labeled enzyme is fused to the target protein, the fusion product is bound to a fixed substrate, and the labeling enzyme is biochemically Protein excision is required. All of the above examples require special column and expensive reagents. 6 d 1304810 Plant seed oil body is a storage organ for budding and fuel for growth of young plants (this AHC 1996. Plant Physiol. : 1055-1061., Peng CC and Tzen " JCT 1998. Plant Cell Physiol. 39: 35-42., Frandsen GI, 2001.

Physiol· Plant. 112: 301-307.)。油體係由三酸甘油酯基質 (triacylglycerol),外被單層磷脂(phospholipids)及蛋白質所圍繞, 其大小為一直徑0.5-2μιη之球體。(ChenJ.C.F.,etal·,1999. Plant Cell Physiol· 40: 1079-1086.)。油體因含有油膜蛋白質,該蛋白提供 φ 的立體結構排除性及電負性排斥,使得油體在細胞中或在分離製備中都 特別穩定(Tzen J.T.C. and Huang A.H.C. 1992. J. Cell Bi〇i· Π7. 327-335., Tzen J.T.C., et al. 1992. J. Biol. Chem. 267: 15626-15634.)。 從能夠表現油膜蛋白融合體的轉殖植物提取的種子油體,已經被用為 重組蛋白質生產和純化的攜帶载體(Van R〇〇i j en G. j. H. and M〇丨㈤坪Μ. M. 1995. Biotechnology. 13:72-77.)。一經離心,於油體表面之目標蛋白 質與油膜蛋白質之融合體,猶如"浮滓(scum)”懸浮於溶液表面,可以容 • 易地被分離回收(Tzen J.T.C.,et al. 1997. J. Biochem. - 121:762—768.)。回收的油體可直接在設計過的接合子(linker)序列上以 專一性蛋白酶水解切割,使目標蛋白質從油膜蛋白分離。從重組油體釋 出的南純度目標蛋白隨即可由離心上清層回收。利用重組油體的操作方 法,與配體交換純化方法比較,相對地較廉價,但仍須使用高價的蛋白 酶。 此外,在先前的發明如美國專利第565〇554號中,為使目標蛋白質從結 α /由體蛋白質分離出,於純化時所加入之蛋白酶必須對接合子序列中切 割位點具備專一性。同樣地,目標蛋白質不能包含相同的切割位多肽序 1304810 列(cleavage site)以避免目標蛋白質被切割。這些考量限制了能用於以 此油體為基礎的純化方法中蛋白酶的選擇。 内含肽(intein)為可自我裂解的多肽,一開始係由酵母菌 ⑽/efts TFP1基因中發現(Kane,P. M·,et al,Physiol· Plant. 112: 301-307.). The oil system consists of a triacylglycerol matrix surrounded by a single layer of phospholipids and a protein having a size of 0.5-2 μm in diameter. (ChenJ.C.F., et al., 1999. Plant Cell Physiol. 40: 1079-1086.). The oil body contains oil film protein, which provides stereo structure exclusion and electronegativity repulsion of φ, making the oil body particularly stable in cells or in separation preparation (Tzen JTC and Huang AHC 1992. J. Cell Bi〇i · Π 7. 327-335., Tzen JTC, et al. 1992. J. Biol. Chem. 267: 15626-15634.). Seed oil bodies extracted from transgenic plants capable of expressing oil film protein fusions have been used as carrier carriers for recombinant protein production and purification (Van R〇〇ij en G. j. H. and M〇丨 (五) Μ M. 1995. Biotechnology. 13:72-77.). Once centrifuged, the fusion of the target protein and oil film protein on the surface of the oil body is like “scum” suspended on the surface of the solution, which can be easily separated and recovered (Tzen JTC, et al. 1997. J. Biochem. - 121:762-768.) The recovered oil body can be directly cleaved by a specific protease on the designed linker sequence to separate the target protein from the oil membrane protein. The South Purity Target Protein can then be recovered from the centrifugation supernatant. The method of using the recombinant oil body is relatively inexpensive compared to the ligand exchange purification method, but high-priced proteases must still be used. In addition, the prior inventions such as the US patent In No. 565〇554, in order to separate the target protein from the knot α/body protein, the protease added during purification must have specificity for the cleavage site in the zygote sequence. Similarly, the target protein cannot contain the same The cleavage site is cleavage site to avoid cleavage of the target protein. These considerations limit the purification method that can be used on this oil body. The choice of proteases in the process. Intein is a self-cleavable peptide, originally found in the yeast (10)/efts TFP1 gene (Kane, P. M., et al,

Science 1990,250,651-657)。在爾後的研究中揭示,在5>ceVMA内含 肽的分離區之胺基酸修改後,可以產生在體外自我裂解(in vitr〇 splicing)的系統(Chong, S.,et al,j. Biol. Chem. 1996, 271, 22159-22168)。 在所有經基因工程改造過的内含肽中,内含特 別引人注目,因為其分別可以二硫蘇糖醇(14_dithi〇threit〇1,DTT) (Mathys,S.,etal,Gene 1999,231,1-13)及溫度的改變來誘導其 自我裂解(Southworth,Μ· W.,et al,BioTechniques 1999,27, 110-120)。由内含肽引發的肽鏈分離開始於一個在处e GyrA内含肽的氮 端,經由N-S acyl重整(rearrangement)形成的硫酯(thioester)鍵。而 DTT可切斷這個硫酯鍵並引發氮端的斷裂(Telenti,A.,的&1,叉Science 1990, 250, 651-657). In a later study, it was revealed that the amino acid in the isolation region of the 5>ceVMA intein can be modified to produce a system of in vitro cleavage (in vitr〇splicing) (Chong, S., et al, j. Biol). Chem. 1996, 271, 22159-22168). Among all genetically engineered inteins, the inclusion is particularly striking because it can be dithiothreitol (14_dithi〇threit〇1, DTT) (Mathys, S., et al, Gene 1999, 231 , 1-13) and temperature changes to induce self-cleavage (Southworth, Μ W., et al, BioTechniques 1999, 27, 110-120). Peptide chain cleavage initiated by intein begins with a thioester bond formed at the nitrogen end of the eGyrA intein via N-Sacyl rearrangement. DTT can cleave this thioester bond and initiate the cleavage of the nitrogen end (Telenti, A., & 1, fork)

Bacteriol. 1997,179,6378-6382)。相對的,在可容許的溫度下,在 物DnaB内含肽的碳端天門冬胺會促成號拍酿亞胺(succinimide)的形成 並造成在碳端的分離。 市場上亦有一種蛋白融合表達及純化系統IMPACTTM-TWIN System (New England Biolabs,Catalog Number E6_S),其顧係透過將表達的 目標蛋白貝與内含肽及幾丁質結合區域(也伽⑽心呢d〇main)开多成融 合蛋白質,再通過利用内含肽的可誘導自我裂解活性,在幾丁質層析柱 上將目標蛋轉放出來,達到闕析柱進行蛋白分離純化的方法。此方 的優點之$利用蛋白連接反應,可另將非編碼的胺基酸片段或標 1304810 記物連接至6細蛋自㈣上。❹卜,將目㈣麵到該產品 所使用載Itinteinl的碳端,利用溫度/幽改變可料内含肽發生裂 解,避免了軸嶋編_壞。此㈣入制_含肽標記之 間的目標蛋白經#切分離後,尚可通珊末端的半胱氨酸和C末端的硫醋 鍵連接兩端形成肽鍵’而產生環狀蛋白。Bacteriol. 1997, 179, 6378-6382). In contrast, at the permissible temperature, the peptide-containing carbon-terminal asparagine in the DnaB promotes the formation of succinimide and causes separation at the carbon end. There is also a protein fusion expression and purification system IMPACTTM-TWIN System (New England Biolabs, Catalog Number E6_S), which is based on the expression of the target protein shell and intein and chitin binding region (also gamma (10) heart D〇main) is opened into a fusion protein, and then by using the inducible self-cleavage activity of the intein, the target egg is transferred out on a chitin chromatography column to reach a decanting column for protein separation and purification. The advantage of this side is that by using a protein ligation reaction, a non-coding amino acid fragment or a standard 1304810 can be attached to the 6 fine egg from (4). ❹ , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , After the (4)-incorporated protein-containing protein is separated by the #-separation, it is possible to form a cyclic protein by forming a peptide bond at both ends of the cysteine at the end of the chain and the thioacetic acid at the C-terminus.

這類產品具有以下容易操作的優點,包括單管柱-步驟純化,無需額 外步驟切喊移去親和錄結合蛋㈣;無需蛋白_用即可將目標蛋 白質從融合社錄魏;使㈣絲合物或鼻溫度敝類導與親 合柱的裂解侧;錄達含抑末辭胱倾和娜末端顧鍵的蛋白表 達系統,可用於蛋白質的標記、連接和環化。 然而要有效降低蛋白質的純化成本,仍必須減低純化管柱的使用。如 中華民國專利公告第_9322號,油體和做為親和性母質之缔合蛋白 質:提供-種”從樣品分離翻的分子方法,,,以油體締合蛋白質之特性, 進行非管柱编化方法如離…浮動或尺寸排斥法。 目前,尚未有提供既能無需蛋__即可將目標蛋白質從融合體上 分離釋放,簡時使關_濟_錄式純化方法。 【發明内容】 在本發明中,發明者利用人工油體(奶出㈤&旧_施) 糸統’將趙蛋白質與欲純化之蛋白⑼―内含肽連接,如此可減少純 化的成本並且不需要使用昂貴的蛋白酶來釋出目標蛋 發明概沭 利用轉殖(t刪卿ic)植物表現和純化蛋白質較為昂貴且效果不彰。 根據天脑體其中三健要的成份,即三酸甘誠、磷脂和油膜蛋白質 的相對比例,可財齡(in vitrQ)建構穩定之人工峨奶出㈣ 1304810 oil bodies,AOBsXTzen, C. etal,J. Biochem. 1998, 123, 319-324., Tai, K. etal, Biosci. Biotech. Biochem. 2002, 66, 2146-2153.,Peng, C. etal’ Biotechnol. Prog. 2003,19,1623-1626·)。藉由此可行的 技術,本發明之A0B系統可以提供生產純度相同且能提升產量,較傳統利 用來自轉殖植物中的油體更為簡單快速。 A0B系統亦具有一種優勢’即在純化重組蛋白質時,可回收因大腸桿菌 過度表現使传異源性可;谷蛋白質被包覆於包涵體(inclusi〇n b〇dies)成 非可溶性的蛋白質型態。許多在大腸桿菌中過度表現的異源性可溶蛋白 質會傾向形成不可溶之包涵體。為使表現後重組蛋白質功能可被還原, 已有數項蛋白f復性(renature)技術被發展出來⑽ddelberg A. p. j. 2002· Trends Biotech. 20:437-443.)。在A0B系統中,目標蛋白質的摺 疊過程是無合油縣自f之厭水端齡。郷細_冑過程中將厭 水4伤包埋入二酸甘油酯基質,如此在娜分子表面留下所欲得的蛋白質 自行摺疊成正確構形’並正確恢復它的魏。這雜形類似發生在伴伯 蛋白複體(Chaperone complex)中厭水袋(hydrophobic pocket)中由伴侣 蛋白協助的摺疊(Hartl F.U. 1996. Nature 381: 571-579.)。 然而,即便利用A0B可以有效的節省純化蛋白質的成本,但利用蛋白酶 如factor Xa或thrombin來將目標蛋白質自重組油膜蛋白結合多肽分離仍 相當昂貴’因此限制了這項技術的實用性。 在本發明中,發明者利用A0B系統,將油膜蛋白質與欲純化之蛋白質以 -内含肽連接’如此可減少純化贼本並且不需要使料貴的蛋白酶來 釋出目標蛋白質。 本發明突出之特色,在於達成以微生物和較高等的生物體進行表現和 以基於油财蛋自f自剪接磁内含肽(intein)的綠實施便捷的目 1304810 標蛋白質之純化。所彻的表現生碰之較佳實闕為大麟_及酵母 菌。本發明亦有_表現及純化此產品多肽所使用之生物成份。詳言之, 本發明特別包括—結合產品多肽之蛋白純化構體(construct)。 一般而言,本發明所包括的生物成份如下: a. 個表達的蛋白純化構體,其係由三個部分構成,分別是一必須的 & ’由體蛋白質或多肽,包含内含肽(intein)之連接多肽,及目 標蛋白質。 b. —建立蛋白純化構體所用的重組基因; c. 一重組表現載體,其中包含此重組基因; d. 已經表現载體轉形(transf〇rm)該表現載體的細胞或較高等生物 體; e. —與連接多肽相連之結合油體蛋白基因; f. 此目標蛋白質與連接多肽在碳端或氮端相連;及 g. 此目標蛋白質可再與其對應前蛋白多肽(pr〇pr〇tein,pr〇卿他) 相連接。 換言之,本發明係關於一種多肽,包括: a. —結合油體之末端肽;及 b. —内含肽(intein)胺基酸片段,其係連接至末端肽。 此多肽另包含一目標多肽’該目標多肽亦連接至内含肽。 本發明使用的蛋白純化構體含『結合油體的蛋白部分—連接多肽 (connecting peptide)-目標蛋白質』、『目標蛋白質_連接多狀 (connecting peptide)-結合油體的蛋白部分』、『結合油體的蛋白部分_ 連接多肽(connecting peptide)-前肽-目標蛋白質』及『前肽目標蛋 11 1304810 • _連接纽(eGnneetin請_e)~結合油體的蛋白部分』等組合模 、 / U段與結合油體蛋白部分能結合到人卫油體⑽)。第二片段是 連接序列,該序列之内含肽可誘導自我裂解活性,對銜接目標蛋白進行 _。第三個片段是目標蛋白質,其可以是任何來自自然界或人工合成 ❹肽’且功能為蛋白質,較佳之實例為酶。一般而言,目標蛋白質由 早-多肽或多單位產品多肽組成。此蛋白肢符合_需求的最終產品。 此目標蛋白可為多種形式。第一種為單-產品多肽。第二種為單—產 • 品多狀的多次重複,其中以互連多肽相連。在這兩種情況中,皆含有相 通的内含肽序列,因此可以同樣的溫度、师或化合物刺激來裂解。裂 解所使用之較佳化合物為二硫蘇糖醇(dithiothreitol,卿);裂解使用 之溫度範圍為0。(:至5(TC,較佳之溫度範圍為代至抓,更佳之溫度範 圍為25°C至3rC ’最佳之溫度為3rc ;裂解使用之师範圍為佩^ ρΗ9· 5 ’較佳之pH值範圍為ριΐ7至pH9,最佳之pH值為pH7. 5。 蛋白純化構體中的結合油體片段通常為結合油體蛋白 body-binding protein),其包括一個被截斷的,改變過或功能上修飾的 • (這裡指功能較佳的)。結合油體的蛋白具有對油體或油體衍生物的高親 . 合力,特別對人造的油體⑽)的親合力更高。因具有強親合力,因此一 般而言,結合油體蛋自對油體的結何使結合混合純容純與其他細 胞萃取物分賴。結合油體蛋白的陳佳實施例包括從任何來源得到的 油膜蛋白,尤其在是源於植物及一改進其功能的版本。結合油體蛋白的 的最佳實施為油膜蛋白(〇leosin)。油膜蛋白可源於植物,較佳之來源 為菜籽油(canola oil)。 其他結合油體蛋白,與油體能強力地結合也能夠以同樣方式實施同樣 功能以獲得相同效果,基於它們是蛋白純化構體中結合油體蛋白的部 12 1304810These products have the following easy-to-operate advantages, including single-column-step purification, without the need for additional steps to remove the affinity-bonded egg (4); without the use of protein - the target protein can be recorded from the fusion; The cleavage side of the sputum and the temperature of the affinity column; the protein expression system containing the cysteine and the end of the bond can be used for labeling, ligation and cyclization of the protein. However, in order to effectively reduce the purification cost of the protein, it is still necessary to reduce the use of the purification column. For example, in the Republic of China Patent Bulletin No. _9322, the oil body and the associative protein as an affinity parent material: provide a molecular method for separating and detaching from the sample, and the properties of the oil-associated protein are used for non-management. The column coding method is as follows: floating or size exclusion method. At present, there is no provision for the separation and release of the target protein from the fusion body without the need of egg __, and the simple method is to clean the method. In the present invention, the inventors use artificial oil bodies (milk out (five) & old) to link the Zhao protein with the protein (9) to the intein to be purified, thereby reducing the cost of purification and eliminating the need for use. Expensive proteases to release target eggs. The use of transgenic plants to express and purify proteins is more expensive and less effective. According to the ingredients of the three brains of the brain, namely, tristearate, phospholipids Relative to the ratio of oil film protein, can be constructed in (in vitrQ) stable artificial milk (four) 1304810 oil bodies, AOBsXTzen, C. et al, J. Biochem. 1998, 123, 319-324., Tai, K. etal , Biosci. Biotech. Bioc Hem. 2002, 66, 2146-2153., Peng, C. etal' Biotechnol. Prog. 2003, 19, 1623-1626.) By virtue of this feasible technique, the A0B system of the present invention can provide the same purity and energy production. Increasing yield is simpler and faster than traditional use of oil bodies from transgenic plants. The A0B system also has an advantage that when the recombinant protein is purified, it can be recovered due to excessive expression of E. coli to enable heterologous transmission; Covering inclusion bodies (inclusi〇nb〇dies) into non-soluble protein forms. Many heterologous soluble proteins that are overexpressed in E. coli tend to form insoluble inclusion bodies. Can be reduced, several protein f renature techniques have been developed (10) ddelberg A. pj 2002· Trends Biotech. 20:437-443.) In the A0B system, the folding process of the target protein is No Oil County From the anti-water end of f. In the process of 郷 fine_胄, the anaesthetic 4 wounds are embedded in the diglyceride matrix, so that the desired protein is left on the surface of the molecule to fold into the correct configuration and restore it Wei. This hybrid resembles a chaperone-assisted folding in a hydrophobic pocket in the Chaperone complex (Hartl FU 1996. Nature 381: 571-579.). A0B can effectively save the cost of purified protein, but the use of proteases such as factor Xa or thrombin to separate the target protein from the recombinant oil membrane protein-binding polypeptide is still quite expensive' thus limiting the utility of this technique. In the present invention, the inventors used the A0B system to link the oil film protein to the protein to be purified by the intein. Thus, the purified thief can be reduced and the expensive protease is not required to release the target protein. The outstanding feature of the present invention is that it achieves the purification of microorganisms and higher organisms, and the self-splicing of the intein based on the oily egg to facilitate the purification of the target protein. The best performance of the actual performance is the big Lin _ and yeast. The invention also has the biological components used to express and purify the polypeptide of the product. In particular, the invention specifically includes a protein purification construct that binds to a product polypeptide. In general, the biological components encompassed by the present invention are as follows: a. An expressed protein purification construct consisting of three parts, each of which is a required & 'in vivo protein or polypeptide, comprising an intein ( Intein) linked polypeptide, and target protein. b. - establishing a recombinant gene for use in purifying the protein; c. a recombinant expression vector comprising the recombinant gene; d. a cell or a higher organism having the expression vector transfl〇rm; e. - a binding oil body protein gene linked to the linked polypeptide; f. the target protein is linked to the linked polypeptide at the carbon or nitrogen term; and g. the target protein can be further associated with the proprotein polypeptide (pr〇pr〇tein, Pr〇qing he) connected. In other words, the invention relates to a polypeptide comprising: a. - a terminal peptide that binds to an oil body; and b. - an intein amino acid fragment linked to a terminal peptide. The polypeptide further comprises a polypeptide of interest. The polypeptide of interest is also linked to an intein. The protein purification construct used in the present invention contains "the protein portion of the oil body-connecting polypeptide-target protein", "the target protein_connecting peptide-binding protein portion of the oil body", and the combination The protein part of the oil body _ connecting peptide (propeptide) - propeptide - target protein and "propeptide target egg 11 1304810 • _ linkage (eGnneetin _e) ~ combined with the protein part of the oil body" and other combination mode, / The U segment and the bound oil body protein moiety can bind to the human body oil body (10)). The second fragment is a ligated sequence in which the peptide contains a self-cleaving activity and _ is attached to the target protein. The third fragment is the target protein, which may be any natural or synthetic quinone peptide' and functions as a protein, preferably an enzyme. In general, the protein of interest consists of an early-polypeptide or a multi-unit product polypeptide. This protein limb meets the final product of _ demand. This protein of interest can be in a variety of forms. The first is a mono-product polypeptide. The second is a multiple-multiple repeat of a single-product, in which the interconnected polypeptides are linked. In both cases, the same intein sequence is included and can therefore be cleaved by the same temperature, division or compound stimulation. The preferred compound for cleavage is dithiothreitol (clear threitol); the temperature range for cleavage is zero. (: to 5 (TC, the preferred temperature range is from generation to grab, and the better temperature range is 25 ° C to 3 rC 'The optimum temperature is 3rc; the range of cracking used is the best pH value of pe Η 9 · 5 ' The range is from ριΐ7 to pH9, and the optimal pH is pH 7.5. The bound oil body fragment in the protein purification construct is usually a binding body protein (body-binding protein), which includes a truncated, altered or functionally Modified • (This refers to better function.) Proteins that bind to oil bodies have a high affinity for oil bodies or oil body derivatives, especially for artificial oil bodies (10). Because of its strong affinity, it is generally combined with the oil body egg to self-align the oil body to make the combination of pure pure content and other cell extracts. Examples of the combination of oil body proteins include oil film proteins obtained from any source, especially from plants and a version that improves their function. The best implementation of binding to oil body proteins is oil film protein (〇leosin). The oil film protein may be derived from a plant, preferably a canola oil. Other combinations of oil body proteins, which can be strongly combined with oil bodies, can perform the same function in the same manner to obtain the same effect, based on the fact that they are the part of the protein purification construct that binds oil body protein 12 1304810

此種用於純化目標蛋白質之混合物,包含本發明之雜合多肽及用於和 此雜合多肽中結合油體肽結合之油體,此結合油體肽與油體有高度親合 性。本發明之雜合多肽係利用酵母菌或細菌宿主細胞所生產,較佳之實 施例為大腸桿g。雜合錄係指—結合油體之末雜;-位於結合油體 • 肽與目標蛋白質間的内含肽(intein)胺基酸>[段序列,該片段自我剪接 反應功能可用化合物、溫度或pH值改變誘導啟動;及一目標多肽,其係 φ 單一產品肽或單一產品肽之多重複製品,而鄰接產品肽間以内含肽 (intein)相連。另目標多肽之前肽亦可與目標多肽以操作性方向相連, 而再透勒魏與賴蛋自滅。雜合乡馳狀實關餘油膜蛋白_ 半胱胺酸蛋白質’其與三酸甘油醋,碌脂與而組成廳系統。油體係由三 酸甘油脂與伽組成’從植物中提煉,較佳之來源為菜籽油(c細^ oil)。AOBs係於1 mL的1〇福鱗酸鈉緩衝液(pH 7·5)中,加入15呢三 酸甘義(自Leader Price ca,TW取得的菜籽油(_1&)中分離而 得),15_磷脂,及含55(^g油膜蛋白_雜合多肽大腸桿菌碎片沉澱層 • 所組成。油體由菜軒油中提煉後,以人工合成,油體中三酸甘油脂與碗 . 月旨之比例為50 : 1至1 : 50,較佳之實施例為100 : : 1〇〇,最佳之實 施例為1GG :卜嶙脂與雜合多肽之_為1 : 10至1〇 :卜較佳之實施例 為1 : 4至4 : 1,最佳之實施例為丨:4。Such a mixture for purifying a protein of interest comprises a hybrid polypeptide of the present invention and an oil body for binding to an oil body peptide in the hybrid polypeptide, and the combined oil body peptide has a high affinity with the oil body. The hybrid polypeptide of the present invention is produced using yeast or bacterial host cells, and a preferred embodiment is the large intestine rod g. Heterozygous refers to the combination of the end of the oil body; the intein amino acid that binds between the oil body peptide and the target protein>[sequence sequence, the fragment self-splicing reaction function available compound, temperature Or a pH change induces initiation; and a target polypeptide which is a multiplex of a single product peptide or a single product peptide, and adjacent product peptides are linked by an intein. In addition, the peptide of the target polypeptide may also be linked to the target polypeptide in an operational direction, and then the self-extinguishing and the lyophilized egg. The heterozygous township is the key to the oil film protein _ cysteine protein, which is combined with triglyceride and vinegar. The oil system is refined from plants by the composition of triglyceride and gamma, preferably from rapeseed oil (c fine oil). AOBs were added to 1 mL of 1% sodium sulphate buffer (pH 7.5), and added to 15 succinate (separated from rapeseed oil (_1&) obtained from Leader Price ca, TW) , 15_ phospholipid, and containing 55 (^g oil film protein_heteropolypeptide E. coli debris sediment layer • composed of oil body extracted from vegetable Xuan oil, artificial synthesis, oil body triglyceride and bowl. Month. The ratio is 50:1 to 1:50, and the preferred embodiment is 100: :1〇〇, and the best embodiment is 1GG: 嶙 嶙 and heterozygous polypeptide _ is 1: 10 to 1 〇: The preferred embodiment is 1: 4 to 4: 1, and the preferred embodiment is 丨: 4.

次上轉譯後的加I過程。它由—㈣分子_剪切—連接反應組成。蛋白 質内含肽是-個蛋白質前體中的多肽序列,可以催化自身從蛋白質前體 中斷裂,使_的蛋白質外酿連滅賴的蛋自f。本翻㈣含狀作 為目標蛋自質在重組雜合乡財扮演的剪接元件。 13 1304810 . t组基因所編碼之蛋白純化構體包含王個麵#段,各為本構築之三段 , 乡肽相編碼。#段之测以使結合油體蛋白基因或目標蛋自質之基因 f 片段能優先被讀取。較佳的蛋白純化構體為使結合油體蛋白基因片段能 優先被讀取。基因片段可以是以人工合成或由天然來源取得。 目標蛋白質的DNA序列來自舰或自然分離之基因組或合成之脆序 列。 包含重絲因之表現讎·導縣絲核細絲現本發明之蛋⑽ φ 化構體。該表現載體包含蛋白純化構體基因與基礎載體片段。基礎載體 片段可包括能進行適當之轉錄,轉譯,表現型,短暫型或其他表現調控 片段,RNA結合調控或與對產品進行表現後操控的DNA序列。該表現載體 -般而言包括結構性特色如-啟動子,—操作子…調控序列與一轉譯 終止訊息。表現載體可從任能提供前述特色之宿主_或高等生物體 相容的基礎載體合成之。表現載體的調控序列將能專一性地,或者某歧 情形下適度地相容於原核或真核宿主細胞或高等生物。 能指導蛋白純化構體之分泌的魏後之調控序列 • ,亦能被包含於表現載體内。較佳的表現載體為具備同時能作用於宿主細 _ 胞或高等生物體中,可受刺激調控而使得蛋白純化構體過度表現。 . 經轉形之原核或真核細胞或攜帶適當重組之原核或真核載體之較高等 生物體組成本發明中的轉形微生物與高等生物體。原核細胞宿主者包括 任何能順從表現外源蛋白之原核細胞。較佳實施例為大腸桿菌。真核細 胞包括單細胞生物體如酵母細胞,以及源自高等生物體如植物,昆蟲或 哺乳動物的不死細胞。較佳的真核宿主為酵母菌。有用的高等生物體宿 主包括具有能被轉形的生殖細胞之高等植物及動物。植物包括煙草,玉 米,黃丑,及產果植物,無脊椎與脊椎動物如魚,鳥和哺乳類特別包括 1304810 羊,山羊,牛’馬以及豬。 本發明也包括一個經培養的,由上述表現載體轉形的宿主細胞或能夠 表現這個為純化蛋自方法而設計的體構祕轉雜物或動物。 一般而言’本發明所要求的方法包含以下: (a) 被攜帶蛋白純化構體之重組基因序列的重組表現紐所調節的宿 主細胞或宿主生物體; (b) 以一基於油體之分離技術來純化蛋白純化構體產品;及 (c) 在一次或多次程序中以溫度或化學品的刺激使蛋白純化構體自我 切割以製備產品多肽。 本發明所載之表現方法的步驟係依據微生物或較高等生物蛋白表現。 步驟需要將重組基_人適當的基本載體,再以此重組載體轉形宿主細 胞或較高等生物。較佳情況下’該重域體於宿主細胞或較高等生物内 表現蛋白純化構體之可溶性產品,或表現於細胞質中之不可溶產品,或 成為宿主細胞或較高等生物泌出產品。t選擇較高等生物絲現宿主, 該生物受精生_胞職_,且娜後生物以—般賊難術養殖。 純化方法的步驟需使蛋白純化構體結合於人工油體上,並將之與其他 的細胞性組成物、碎片及培養液中分離。目標蛋白質之獲得,係對蛋白 純化構體上内含肽’在溫度、pH值或化合物的刺激下進行自我裂解,進 而將該目標蛋白質與切割酶分開。 此純化步驟的另-方法為將蛋白純化構體從纖分離後,經過純化過程 及用溫度或化學品_激,產生包含目標蛋自質及結合油體蛋白之混人 物。此混合物可利用Α0Β分離油體蛋白,並純化目標蛋白質。 口 本發明係關於一種純化目標蛋白質方法,包括以下步驟: a.製備雜合多肽,其包含·· 15 !3〇481〇 i. 一結合油體之末端肽; U.一位於結合油體肽與目標蛋白質間的内含肽(intein)胺基酸片 段’該片段自我剪接反應功能可用化合物、溫度或pH值改變誘導啟動; 及 111. 一目標多肽,其係單一產品肽或單一產品肽之多重複製品,而鄰 接產品肽間以内含肽(intein)相連; b. 混合多肽與油體,而形成產生油體混合物; c. 將油體混合物從其餘細胞萃取物之碎片分離; d·將目標多肽從結合油體部分切割;及 e·將目標多肽從其餘油體混合物分離。 根據本發明之方法,其中步驟b之混合物可使用超音波震盪產生;步驟 c之分離可用離心處理;步驟e之目標多肽可用離心將其與油體混合物之 剩餘物中分離。 本方法較佳的具體實施例包括重組基因的表現,其中重組基因的組成 核酸片段包括賴蛋自(或關於其改進捕的版本),内含肽及和單一產 品多肽或多單位產品纽。此外較佳的具體實關包括使狀腸桿菌或 酵母菌為表現餘,並雜—如溫度,營養物,異丙基硫代半乳糖普 (isopropyl thi〇galactoside,IPTG),吲哚丙烯酸(ind〇le acryHc acid) ’破《敝物等料纟統宿錄助含的蛋自純化構體 之表現。更佳的實施例包括原核細胞之表現載體祕,其中合併雙質體 的構築,和酵母細胞之_表現纽,其巾合併的雜健(油咖e vector)具有一大腸桿菌和一酵母菌的複製起始點(〇rigin μ replication) ° 發明詳細說明 16 1304810 • 、、’°合運用纽細及宿主細胞切主生物體的生物合賴制,用於表 ,, 現―個外源蛋白質已屬生化蛋白合射廣泛習知的技術。本發明運用新 穎的改良表現技術方法結合-種以油體為基礎的分離技術,建立—種前 未有而成本低廉间效率的生物合成方法。透過選用内含肽作為分離 標蛋白之裂解機制。本發明免除昂貴機器和試劑之使用以及漫長化學 . 合成所需時間。 - 本發縣方法整合能提供充分高效率以及降低純化髓花費的因素。 • 為本發明使用的娜系統所設計的蛋白純化構體中,獨特的蛋白與結合油 體部分,可實現乾淨且輕㈣將目標蛋"由其他成分中分離。離心是 本發明情最常使㈣分離技術,從而減少各式純絲柱和昂貴的試劑 的費用。 ΙΑ·表現方法一宿主細胞 ^發雜賴生物學綠,_賤纽蛋自軌獅之魏載體轉 形宿主細胞,以驅使宿主細胞表現該蛋白純化構體。載體中蛋白純化構 • 體基因的製備,係將蛋白純化構體的編碼核酸片段插人適當基礎載體中。 - 在·'鋪體構財針,結合賴蛋㈣腿片段,_物的油膜蛋白 . 基因為例,將該基因插入一相容於待轉形宿主的基礎質體内。該基礎質 ’ 體包含必須的調控序列以利大量表現置於下游的基因片段。 -合成的臟序列’其中序列編碼為内含肽,被插入靠近結合油體蛋白 基因的3,端。在靠近結合蛋白基因3,職有—限制酶切割位以便内含狀 之麵序舰插人。此外,至少—倾_限_蝴位(紐中間限制 酶切割位)也必須設計於此合成的内含肽之DNA序列中,如此,目標蛋白 質的DNA片段隨後才能插入正確讀框内。若無這些限制酶切割位存在,依 17 1304810 照Sambrook, J., et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1989)之 標準程序實施後以定點突變設計導入該位置。Add the I process after the translation. It consists of - (iv) molecular_shear-linking reaction. The proteinaceous intein is a polypeptide sequence in a protein precursor that catalyzes its own cleavage from the protein precursor, allowing the protein to be succulent from the fucking egg. This turn (4) contains the splicing element as the target egg self-quality in the recombination of the hybrid. 13 1304810. The purified structure of the protein encoded by the t-group gene contains the Wangzi no.# segment, each of which is the third segment of the construction, and the township peptide phase is encoded. The measurement of the # segment is such that the gene f fragment that binds to the oil body protein gene or the target egg is preferentially read. A preferred protein purification construct is such that the binding oil body protein gene fragment can be preferentially read. Gene fragments can be obtained synthetically or from natural sources. The DNA sequence of the target protein is derived from the genomic or synthetically fragile sequence of the ship or naturally isolated. Including the performance of the heavy wire 雠·Guxian County silk core filaments are now the egg of the invention (10) φ chemical body. The expression vector comprises a protein purification construct gene and a base vector fragment. The base vector fragment can include DNA sequences that are capable of proper transcription, translation, phenotype, transient or other expression regulation, RNA binding regulation or manipulation with the product. The performance vector generally includes structural features such as a promoter, an operator, a regulatory sequence, and a translation termination message. The expression vector can be synthesized from a host or a higher organism compatible base vector which provides the aforementioned features. The regulatory sequences of the expression vector will be specifically or in a heterozygous manner compatible with prokaryotic or eukaryotic host cells or higher organisms. The post-Wei regulatory sequence that directs the secretion of the protein purification construct can also be included in the expression vector. A preferred expression vector is capable of acting on a host cell or a higher organism at the same time, and is stimulated to cause excessive expression of the protein purification construct. Transduced prokaryotic or eukaryotic cells or higher organisms carrying appropriately recombinant prokaryotic or eukaryotic vectors constitute the transformed microorganism and higher organism of the present invention. Prokaryotic cell hosts include any prokaryotic cell that is compliant with foreign proteins. A preferred embodiment is Escherichia coli. Eukaryotic cells include single cell organisms such as yeast cells, as well as undead cells derived from higher organisms such as plants, insects or mammals. A preferred eukaryotic host is a yeast. Useful higher organism hosts include higher plants and animals with germ cells that can be transformed. Plants include tobacco, maize, yellow ugly, and fruit-producing plants, invertebrates and vertebrates such as fish, birds and mammals, including 1304810 sheep, goats, cattle, horses, and pigs. The invention also encompasses a cultured host cell transformed from the above expression vector or a body composition or animal capable of expressing this purified egg method. In general, the methods claimed in the present invention comprise the following: (a) a host cell or host organism regulated by recombinant expression of a recombinant gene sequence carrying a protein purification construct; (b) an oil-based separation Techniques for purifying a protein purified construct product; and (c) self-cleaving the protein purification construct by temperature or chemical stimulation in one or more procedures to prepare a product polypeptide. The steps of the method of expression contained in the present invention are based on microbial or higher biological protein expression. The step requires the recombinant base to be a suitable basic vector, and the recombinant vector is then transformed into a host cell or a higher organism. Preferably, the heavy domain exhibits a soluble product of the purified structure of the protein in the host cell or higher organism, or an insoluble product expressed in the cytoplasm, or becomes a host cell or a higher biologically secreted product. t select the higher organism silk host, the creature is fertilized _ cell _, and Na's creature is bred in a thief. The purification step requires the protein purification construct to bind to the artificial oil body and separate it from other cellular components, fragments and culture. The target protein is obtained by self-cleaving the intein on the protein purification construct under the stimulation of temperature, pH or compound, thereby separating the target protein from the cleavage enzyme. Another method of this purification step is to separate the protein purification construct from the fiber, after purification, and by temperature or chemical reaction, to produce a mixture comprising the target egg self-mass and the binding oil body protein. This mixture can separate oil body proteins using Α0Β and purify the target protein. The present invention relates to a method for purifying a target protein, comprising the steps of: a. preparing a hybrid polypeptide comprising: · 15 ! 3 〇 〇 〇 一 一 一 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合 结合An intein amino acid fragment to the target protein's self-splicing reaction function can be initiated by a compound, temperature or pH change; and 111. a target polypeptide which is a single product peptide or a single product peptide Multiple repeats, while adjacent product peptides are linked by inteins; b. mixing the polypeptide with the oil body to form an oil body mixture; c. separating the oil body mixture from the remaining cell extract fragments; d· The polypeptide of interest is cleaved from the bound oil body; and e. separates the polypeptide of interest from the remaining oil body mixture. According to the method of the present invention, wherein the mixture of step b can be generated using ultrasonic oscillation; the separation of step c can be carried out by centrifugation; and the target polypeptide of step e can be separated from the remainder of the oil body mixture by centrifugation. Preferred embodiments of the method include the expression of a recombinant gene, wherein the constituent nucleic acid fragments of the recombinant gene include lynized egg (or a modified version thereof), an intein, and a single product polypeptide or a multi-unit product. In addition, the preferred specific examples include E. coli or yeast for performance, and impurities such as temperature, nutrients, isopropyl thi〇galactoside (IPTG), 吲哚acrylic acid (ind 〇le acryHc acid) 'Break the performance of the eggs from the purification of the sputum and other materials. More preferred embodiments include the expression vector of prokaryotic cells, wherein the construction of the merged diplasts, and the expression of the yeast cells, the combined health of the towel (Eco-e vector) having an Escherichia coli and a yeast Replication start point (〇rigin μ replication) ° Detailed description of the invention 16 1304810 • , '° combined use of the host and the host cell to cut the host organism's biological integration system, for the table, now - a foreign protein has It is a well-known technique for biochemical protein injection. The present invention utilizes a novel improved performance technique combined with an oil body-based separation technique to establish a biosynthetic method that is unprecedented in cost and low in cost. By using the intein as the cleavage mechanism of the isolated protein. The present invention eliminates the use of expensive machines and reagents as well as lengthy chemistry. Time required for synthesis. - This county's method integration provides factors that are sufficiently efficient and reduce the cost of purifying the marrow. • In the protein purification construct designed for the Na system used in the present invention, the unique protein and the combined oil portion can be clean and light (4) separating the target egg from other components. Centrifugation is the most common (4) separation technique of the present invention, thereby reducing the cost of various types of pure wire columns and expensive reagents. ΙΑ·Expression method-host cell 发 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 生物学 贱 贱 贱 贱 贱 贱 贱 贱 魏 魏The purification of the protein in the vector is carried out by inserting the nucleic acid fragment encoding the protein purification construct into a suitable basic vector. - In the 'planting body's financial needle, combined with the lyophilized egg (four) leg fragment, _ the oil film protein. Gene, for example, the gene is inserted into a basal plastid that is compatible with the host to be transformed. This basal body contains the necessary regulatory sequences to facilitate the large representation of gene fragments placed downstream. - Synthetic viscous sequence ' wherein the sequence is encoded as an intein, inserted near the 3' end of the binding oil body protein gene. In the vicinity of the binding protein gene 3, the position-restriction enzyme cleavage site is inserted in order to insert the surface. In addition, at least the tilt-limit_butter position (the intermediate restriction enzyme cleavage site) must also be designed into the DNA sequence of the intein synthesized, such that the DNA fragment of the target protein can then be inserted into the correct reading frame. If these restriction enzyme cleavage sites are absent, site-directed mutagenesis is performed according to the standard procedure of Sam 130, J., et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989). The design is imported into this location.

得到的載體構築是為使蛋白純化構體基因於原處併入較大之載體之中 間基礎载體。任何來自自然界或人工合成的DNA序列皆可插入該中間基礎 載體的限制酶切割位中以併入表現載體之蛋白純化構體基因。恰當的插 入與凟框排列可用已知技術如依照Sambro〇k實驗手冊之核酸定序法定序 結合蛋白與各種融合DNA多肽序列之接合區域予以證實。 替代的合成途徑亦可製備同樣的表現載體。其中一種替代合成途徑, 係任何蛋自純化構體巾雜之__段可連接形成—巾間基因,接著與 第三段0似片段結合產生獨立的蛋白純化構體基因(即分開實體)。經前述 之限制酶_錢财法處理讀,賴立自触類基因可被插 入適當基礎龍。若基礎載體具備適當的獨特限制酶切割位,可應用 Sambrook實驗手冊發表之程序插入載體内。 义種替代方式’在雜飾雜義,麟之帽基因可用 2=顯連接方法轉卿。第繩响犧性的結合油 質基因),用依編⑽實驗手冊之程序,包括 構築適當之關及 匕括 本載體。 制連接方_人卿帽基因的基 與構築最終柄_之_方法,亦 構:序=:::: 軚蛋白質-内含肽-油體結合多 賈号疋目 端。所有限 標蛋白質基因被插入結合油體蛋白與=白=因與/或目 18 1304810 制酶切割,基因段插入,連接及後續 驗手冊。 相關基本程序可參考Sambrook之The resulting vector construct is an intermediate vector for the incorporation of the protein purified construct gene into the larger vector. Any DNA sequence from nature or synthetic can be inserted into the restriction enzyme cleavage site of the intermediate vector vector to incorporate the protein purification construct gene of the expression vector. Appropriate insertion and framing can be confirmed by known techniques such as the binding region of the nucleic acid sequencing sequence binding protein to various fusion DNA polypeptide sequences according to the Sambro〇k experimental manual. Alternative synthetic routes can also be used to prepare the same expression vector. One of the alternative synthetic pathways is that any egg from the purified construct can be ligated to form an inter-tissue gene, which in turn binds to a third stretch of 0-like fragments to produce an independent protein purified construct gene (ie, separate entities). The lyric self-acting gene can be inserted into the appropriate basal dragon by the aforementioned restriction enzyme _ money processing. If the base vector has an appropriate unique restriction enzyme cleavage site, it can be inserted into the vector using the procedure published in the Sambrook Laboratory Manual. Substitute alternatives ‘In the miscellaneous miscellaneous sense, the Lin’s cap gene can be transferred to the Qing. The first phase of the combination of the oily gene) is based on the procedures of the experimental manual (10), including the construction of appropriate and appropriate vectors. The basis of the system and the construction of the final stalk _ _ method, also: the order =:::: 軚 protein-intein-oil body combined with more than the number. All restriction protein genes are inserted into the binding oil body protein with = white = cause and / or mesh 18 1304810 enzyme cleavage, gene segment insertion, ligation and follow-up manual. For related basic procedures, please refer to Sambrook.

麵完权魏_嶋—恤鮮,—刪結合位編碼 帛於師選的表現聽因、轉錄糖區段、轉譯及細胞_譯後修 飾蛋白純化構體之產品蛋白質。 依據則揭的基本方案構築的顧與真鋪體可侧或經修改後作用於The face of the right Wei _ 嶋 恤 恤 , — — — — — — 删 删 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师 师According to the basic scheme of the disclosure, the Gu and the real pavement can be modified on the side or modified.

f當宿主細胞岐生婦合成顧。㈣核細胞㈣,麵最好攜帶訊 心序列與/或其他雛相財说蛋自·麵表錢可分泌至細胞外 或允許其被轉譯後之修飾。 本發明方法健之基_體包含任何_,該麟定宿主相容, 穩定並可允許轉形質成魏主之轉。這樣的雜包括p. h. p_is, et al·,Cloning Vectors ’ %繼触 i985.所發表之一 系列載體在内。 較佳的巾間載體關酶蝴位_含齡·序列而異,彳衫之,即取決 φ 於切割的形式。任何限制酶切割位只要能相容於内含肽DNA序列,或能被 職改變酵素處理(如T4 DNA聚合i|,S1 nuclease,Klen〇w;i段,卿_ nUclease或不_e職udeases) _由加人接合子或轉接子以確保在 接合區域中序列正確且讀框排列正確皆可使用。 用最重組表現載體轉形之宿主細胞之分離係利用表現型或其他設計 於重組載體的特性來篩選。基本上,此類篩選特性包括抗生素抗藥性或 互補宿主缺失功能者。本發明較佳的重組載體用表現型基因包括抗生素 抗藥性表現型,必需胺基酸表現型及其他必需複合物表現型。 經過篩選之轉型宿主細胞,培養於含有營養成分生長因子及維生素供f When the host cell is a maternal synthesis. (4) Nuclear cells (4), it is best to carry the signal sequence and/or other chicks to say that the egg can be secreted outside the cell or allowed to be translated. The method of the present invention comprises any _, the lining host is compatible, stable and allows the transformation of the morphological quality into a genus. Such miscellaneous includes p. h. p_is, et al., Cloning Vectors ’ % followed by i985. The preferred inter-container carrier is different from the age-sequence, and it depends on the form of the cut. Any restriction enzyme cleavage site can be compatible with the intein DNA sequence, or can be changed by enzyme treatment (such as T4 DNA polymerization i|, S1 nuclease, Klen〇w; i segment, qing _ nUclease or not _e job udeases ) _ can be used by adding a splicer or adapter to ensure that the sequence is correct in the joint area and the reading frame is correctly arranged. The isolates of the host cells transformed with the most recombinant expression vector are screened using phenotypes or other properties designed for the recombinant vector. Basically, such screening characteristics include antibiotic resistance or a complementary host deletion function. Preferred anabolic genes for recombinant vectors of the invention include antibiotic resistant phenotypes, essential amino acid phenotypes and other essential complex phenotypes. Screened transformed host cells cultured in nutrient-containing growth factors and vitamins

19 1304810 • 應之培養液,可用非誘導型表現系統產出蛋白純化構體產品蛋白,更佳 ^ 者可用誘導型表現系統,使經篩選之轉型宿主細胞於細胞生長至前-中對 數期以誘導物質處理產出蛋白純化構體產品蛋白。—般而言,將宿主持 續培養數小時,收集並溶解細胞以將細胞中所含蛋白純化構體產品。若 轉形宿主細胞之财為分泌蛋自·構難品,則可將細齡養直至蛋 •自純化構體產品在培養液巾達f求濃度。若宿主_雜將蛋白純化構 黯絲於_質者,則培養_直至其絲韻佳成減。接著以適 • 纽舰解該培養成熟之細胞使翻細歸之巾的蛋白純化構體產品。 若蛋白純化構體產品以不可溶顆粒形式沉積宿主細胞内,則將培養成熟 之細胞溶解並釋出不可溶顆粒,再以離液序列高(cha〇tr〇pic)試劑溶解 此不可溶顆粒並於體外進行重新摺疊。此培養、增殖與溶解之程序可以 批次或持續形式執行。 在兩項可供選擇的蛋白純化構體蛋白生產方法的選擇上,皆將自細胞 獲取的蛋白純化構體的培養液皆用作純化方法中的粗製混合物原料。 IB·表現方法一於高等生物19 1304810 • The medium should be used to purify the protein from the protein using a non-inducible expression system. More preferably, the transformed host cell can be grown in the cell to the pre-intermediate log phase using an inducible expression system. The inducing substance is processed to produce a protein purified construct protein product. In general, the host is cultured for several hours, and the cells are collected and lysed to purify the protein contained in the cells. If the fruit of the transgenic host cell is secreted from the egg, it can be raised to the egg. • The self-purified structure product is concentrated in the culture liquid towel. If the host-hybrid protein is purified and purified, the culture is _ until the silk is good. The protein is then purified by the culture of the matured cells. If the protein purified construct product is deposited in the host cell as an insoluble particle, the matured cells are lysed and released into the insoluble particles, and the insoluble particles are dissolved by a chaotropic solution (cha〇tr〇pic) reagent. Refolding in vitro. This process of culture, proliferation and dissolution can be performed in batch or continuous form. In the selection of two alternative protein purification protein production methods, the culture solution of the protein purification construct obtained from the cells is used as a raw material for the crude mixture in the purification method. IB·Performance method one in higher organisms

P - 本發用的多細胞方法_被基因轉殖,攜帶重組蛋白純化構體基 目之基因表現祕且能表概蛋白純化構體之高等生物。攜帶蛋白純化 構體基因之卡E (Cassette)係由將蛋白純化構體之腿編碼片段插入適 虽基礎卡ϋ製備。該基礎卡雖設計為能與宿主生物體生殖細胞相容且 可合適地與這些細胞的基因物質結合。它能攜帶或經改變而攜帶適當的 啟動子’触子或雛及表現舰鱗供㈣細翻蛋自純化構體之產 品蛋白轉錄,轉譯與轉譯後修飾過程所需。 兩等生物如包括芝麻,玉米’黃豆及於草等植物,或包括如魚或哺乳P - Multi-cell method for the present invention - a gene that is genetically transferred, carries a recombinant protein, and the gene of the purification domain is expressed by a gene that expresses a secret and can purify the structure. The cassette E (Cassette) carrying the protein purification construct gene was prepared by inserting the leg coding fragment of the protein purification construct into a suitable base cassette. The base card is designed to be compatible with the germ cells of the host organism and suitably bind to the genetic material of these cells. It can be carried or altered to carry the appropriate promoter 'traps or chicks and to represent the scales for (4) finely turned eggs from the purified constructs for protein transcription, translation and post-translational modification processes. Second-class organisms include sesame, corn 'yellow beans and plants such as grass, or include such as fish or breastfeeding

20 1304810 (如山羊’牛’馬’兔及鼠)等動物皆可作為此方法的宿主。在宿主 7 =體生殖細胞行有性接合並將受精之生殖細胞以重組表現組合體轉 《後轉殖動物可以藉由在子宮裡重新植入經轉殖的生殖細胞後培養。 植物亦可作為餘。触植輪藉細陳癌_(細如㈣⑽媒介轉 形或將植物原生質體以電穿孔法(eiectroporaton)或顯微注射方法產 生。在轉殖動物或轉殖植物成長後,可於植物的物質中如葉,種子,果 實或動物組織如肉,器官或组織分泌如體液,尿液或乳汁中發現表現的 蛋白純化構體。均質化與/或濃縮提取這些物質,組織或分泌物能產生包 含蛋白純化構體等物質之初步混合物。該混合物之後用於純化目標蛋白。 一般而言,這些方法係依照表一所列文獻提供之技術程序 表一 製備轉殖羊與轉殖鼠之方法20 1304810 (such as goat 'bovine 'horse' rabbits and mice) can be used as a host for this method. In the host 7 = body germ cells are sexually conjugated and the fertilized germ cells are transformed into a recombinant expression assembly. "Transgenic animals can be cultured by re-implanting the transplanted germ cells in the uterus. Plants can also be used as a remainder. The planting wheel uses fine-grain cancer _ (as fine as (4) (10) media transformation or plant protoplasts by electroporation (eiectroporaton) or microinjection method. After the growth of the transgenic animal or the transgenic plant, the plant-derived substance A protein purification construct found in leaves, seeds, fruit or animal tissues such as meat, organs or tissues, such as body fluids, urine or milk. Homogenization and/or concentration of these substances, tissue or secretions can be produced A preliminary mixture comprising a protein purification construct, etc. The mixture is then used to purify the protein of interest. In general, these methods are based on the technical procedures provided in the literature listed in Table 1 to prepare a transgenic sheep and a transgenic mouse.

1. Gordon K., Lee L., Vitale J. A., Smith A. E., Westphal H., and Hennighausen L. (1987) Bio/Technology, 5, 1183-1187. 2. Pittius C. W., Hennighausen L., Lee L., Westphal H., Nichols E., Vitale J. A., and Gordon K. (1988) Proc. Natl. Acad. Sci. USA, 85, 5874-5878. 3. Clark A. J., Bessos H., Bishop J. D., Brown P., Harris S.,Lathe R·,McLenaghan M.,Prouse C., and Simons J. P. (1989) Bio/Technology, 7, 487-492. 製備轉殖兔之方法 1. Buhler Th. A., Bruy ere Th., Went D. F., Stranzinger G., and Burki 21 1304810 Κ. (1990) Bio/Technology, 8, 140-143. Ψ 製備轉殖植物之方法 1. Hooykaas P. J. J., and Schilperoort R. A. (1987) Methods in Enzymology, 153, 305-313. 2. ShillitoR. D., and Potrykus I., (1987) Methods in Enzymology, 153, 313-336. 3. Weissinger A., Thornes D., Maddock S., Fromm M., and Sanford J. _ (1988) Current Communications in Molecular Biology, (Fraley R. T.,1. Gordon K., Lee L., Vitale JA, Smith AE, Westphal H., and Hennighausen L. (1987) Bio/Technology, 5, 1183-1187. 2. Pittius CW, Hennighausen L., Lee L., Westphal H., Nichols E., Vitale JA, and Gordon K. (1988) Proc. Natl. Acad. Sci. USA, 85, 5874-5878. 3. Clark AJ, Bessos H., Bishop JD, Brown P., Harris S., Lathe R., McLenaghan M., Prouse C., and Simons JP (1989) Bio/Technology, 7, 487-492. Method for preparing a rabbit for transfer 1. Buhler Th. A., Bruy ere Th. , Went DF, Stranzinger G., and Burki 21 1304810 Κ. (1990) Bio/Technology, 8, 140-143. 方法 Methods for preparing transplanted plants 1. Hooykaas PJJ, and Schilperoort RA (1987) Methods in Enzymology, 153 , 305-313. 2. ShillitoR. D., and Potrykus I., (1987) Methods in Enzymology, 153, 313-336. 3. Weissinger A., Thornes D., Maddock S., Fromm M., and Sanford J. _ (1988) Current Communications in Molecular Biology, (Fraley RT,

Frey N. M., and Schell J., eds.) Cold Spring Harbor, NY. 4. Lichtenstein C., and Draper J. (1986) in DNA Cloning, vol. II, (Glover D. M. ed. ),IRL Press Ltd.,Oxford UK. II.純化方法Frey NM, and Schell J., eds.) Cold Spring Harbor, NY. 4. Lichtenstein C., and Draper J. (1986) in DNA Cloning, vol. II, (Glover DM ed.), IRL Press Ltd., Oxford UK. II. Purification method

採用A_統的純化方法如圖九所示。為實施純化,將粗輪混合物與娜 結合於結合趙蛋自。蛋自純化顧由於具有結合油_部分而可結合 到A0B。_齡物巾纖組纽_判糊離部除。 ° 為了分離目標蛋白質,純化的蛋域化構體受溫度献學品顧於固 定相或溶_)骑錄自純化構贿料_份,—輕、 内含肽部分,另-為目標蛋白質。其中結合油體部_内含狀:— 端,目標蛋自編摊。响巾躲 離心步驟從結合油體蛋白-内含肽部分分離。 冱反覆的 根據所選用的表現基因’自外連序列釋出的目標 (a)單一目標蛋白質之分離型式,或 、’且成含· ⑹多單元之目標蛋白質,且需要進—步處理。 22 1304810 ―多上植種形式之多單元可合鱗在。在第—種形射,⑽單元可由 -系列相同產品多肽,以内含肽片段連接組成。 另开7式中,多個早位的組成可為一系列相異產品多狀重複的串連, ’由數個_或減產品纽組成之非重複單元。各單位間以上述内含 肽連接。不同的產品多肽會被選擇使它們的物理或化學性質允許以傳統 方式分離。補於單難品綠之錄,时肽糊除作為錄裂解位 置外,且其麟後的對_產品錢的分_亦可提供化學或物理 性區別。單獨或與附著產品多肽結合_含職基_子性、厭脂性、 酸性、驗H抗雜德允許_其他已知乡肽分離綠轉之後,使 用親合性色層分析法、軒交換色層分析法、逆相或正相色層分析法、 對流向式分布、酸或料取使侧的產^乡肽分離。 在選擇這些内含肽片段時要考慮的一侧素是内含狀與其編瑪之基因 片#又位置及改變以提供各種融合肽之基因序列多樣性1多樣性允許多 單元小肽财鱗的表達。目前已知_重複的基因序舰常在重組之 前被宿主生物體重排或刪除。 由於本發明顧内含肽自我裂解的躲,因此僅需要改變溫度、邱值 或以化合物刺激,便能裂解分離目標單白與油體蛋白。因此可以保存產 品多肽的完整性,並且不會傷害到產品多肽的功能性。 III•較佳的具體實施例 -般而言,任何蛋白質皆可財發明大量生產與純化。本方法在大量 生產募肽時制有用’雜在宿主細胞巾財融合形式存細不穩定。 根據以油終自作為結合㈣料之雛綠,本發明歡的具體實 施例將進-步綱本發明讀點。本綠的實施酬之組合與各組成物 基於油膜蛋白。 23 1304810 III· Α·生物性組成物 h蛋白純化構體的DNA及胺基酸序列 a.結合油體蛋白部分 較佳的結合油體蛋自是油膜蛋白或其修飾或改進魏的版本。詳言 之’兀整的賴蛋自基因賴可被插人與大轉旨兼容之表現載體。切 割載體上糖區下贼之腿賴,接雜由平端絲狀連接將基因插 入並形成重組載體。額外地,可在位於油臈蛋白基因5,或3,端處導入一 可供選擇的限制酶切割位置序列,如此可完成接續之操作。 ΠΙ. A. 1· b.内含肽片段 一段短DNA序列’該序列譯碼產物為一内含肽,其可插入完整或部分的 油膜蛋白基S之3或5,端。插人基因時,連接處之醜序列仍然須經前述The purification method using A_ system is shown in Figure 9. To carry out the purification, the coarse wheel mixture and Na are combined with the Zhao egg. Egg self-purification can be incorporated into A0B due to its combined oil_portion. _ Ageing towel group New Zealand _ _ _ _ _ _ _ _ _ _ _ ° In order to isolate the target protein, the purified egg domain is subject to a fixed phase or a solution to the target protein, the light, intein portion, and the other target protein. Including the oil body part _ inclusion: - end, the target egg is compiled. The snare towel is detached from the binding oil body protein-intein portion.冱Repeated target released from the external sequence according to the selected expression gene (a) a separate target protein separation pattern, or ', and contains (6) multiple units of the target protein, and requires further processing. 22 1304810 ―Multiple units of multiple planting forms can be scaled together. In the first form, the (10) unit may consist of a series of identical product polypeptides linked by intein fragments. In the other formula 7, the composition of the plurality of early positions may be a series of repeated repeats of a series of different products, 'a non-repetitive unit consisting of a number of _ or a reduced product. Each unit is linked by the above-mentioned intein. Different product polypeptides will be selected such that their physical or chemical properties allow separation in a conventional manner. In addition to the single difficult green record, the time peptide paste is removed as a cracking position, and the sub-composition of the product _ product money can also provide chemical or physical distinction. Separately or in combination with an attached product polypeptide _ contains a base group, anaerobicity, acidity, test H anti-hybridity allowed _ other known township peptide separation green turn, using affinity chromatography, Xuan exchange color layer Analytical method, reverse phase or normal phase chromatography, separation of the product from the flow direction, acid or feed. The one-sided element to be considered when selecting these intein fragments is the intrinsic shape and the gene-coding fragment thereof. The position and change to provide the gene sequence diversity of various fusion peptides 1 diversity allows multi-unit small peptides expression. It is currently known that replied gene sequences are often removed or deleted by the host organism prior to recombination. Since the present invention utilizes self-cleavage of the intein, it is only necessary to change the temperature, the value of the Qiel or the stimulation of the compound to cleave the target white and oil body proteins. Thus the integrity of the product polypeptide can be preserved without compromising the functionality of the product polypeptide. III. Preferred Embodiments - Generally, any protein can be produced and purified in large quantities. The method is useful in the production of a large number of peptides. According to the greening of the oil-based self-contained (four) material, the specific embodiment of the present invention will further read the present invention. The combination of this green implementation and the composition is based on oil film proteins. 23 1304810 III· Α·Biological composition DNA and amino acid sequence of h protein purification construct a. Binding oil body protein fraction The preferred combination oil body egg is oil film protein or its modified or improved version. In detail, the sturdy lyrics are inserted into the expression carrier that is compatible with the gene. The leg of the thief under the sugar zone on the carrier is cut, and the gene is inserted by a flat-end filamentous connection to form a recombinant vector. Alternatively, an alternative restriction enzyme cleavage site sequence can be introduced at the 5, or 3, terminus of the sputum protein gene so that subsequent operations can be performed. A. A. 1· b. Intein fragment A short DNA sequence 'The decoded product of this sequence is an intein which can be inserted into the 3 or 5 end of the intact or part of the oil film protein group S. When inserting a gene, the ugly sequence at the junction still has to go through the aforementioned

Sambrook et al.中之標準DNA定序法確認。 本發明的特色之-在於内含肽’可在溫度、pH值改變或化合物的刺激 下自動裂解。在此領域中已知的内含肽皆可應用於本發明的範圍之中。 較佳的實施例為内含肽GyrA與妨DnaB。較佳的裂解反應啟動方式 為以溫度、pH值或化合物刺激。 III. A.l c.可變的融合多肽部分 序列的第三部分由目標蛋白質的核酸編碼序列組成,其中較佳的具體 實施例是一單一產品多肽或多個產品多肽單元。其中的單元能依次容納 一或兩個產品多肽。為製備單一產品多肽,單一拷貝基因與由前述列表 選擇出之内含狀的DNA片段連接。為製備合併於多個單元内的二個拷貝產 品多肽,此二產品多肽的核酸序列間之結合係由内含肽之DM序列連接, 單元間再由前述列表選擇出來之互連多肽之核酸序列連接起來。經反覆 的選殖(clone),此基因的多個單元能互相結合。此多單元基因構成可變 24 1304810 的融合多肽片段編碼。 HI. A. 2·重組基因併入表現載體 最終合併了蛋白純化構體基因之重組表現載體可與宿主細胞相容。使 用的载體具備許多共同特色。這些特色包括一相容於宿主細胞的複製起 始點’用於轉錄調控的DNA序列以及轉錄之控制(用於可誘導系統)’ 一有 效的核酶體結合位(原核宿主),一P〇1y_A訊息(真核宿主)。此外,此載 體也可包括表現型基因,調控區域與領導序列。 原核載體,如大腸桿菌的表現其特點為具有以一複製起始點,一用於 轉形菌株篩選的基因標記(表現型)以及一指導目標基因表現的DNA調控 序列。基本的調控序列包含一啟動子(P)以啟動轉錄。一操縱子(〇)以控 制轉錄(開/關轉變)’ 一有效核醣體結合位⑽s)以開始轉譯,以及一轉 錄終止訊息。起始與終止密碼是由插入基因段(蛋白純化構體)提供。 原核載體特別包括一適合之”表現卡匡(eXpressi〇ncassette) ”,其 係基於任何可應用的啟動子/操縱子系統。典型内含於原核載體之啟動子 包括半乳糖、色胺酸(tryptophan)、T7、脂蛋白、鹼性磷酸酶(alkaline phosphatase)、lambda左向或右向啟動子或以上啟動子之組合。半乳糖 及色胺酸操縱子,及溫度敏感性lambda啟動子同樣屬於能包含於原核載 體中典型之開/關型。典型包含於原核載體中之表現型標記包括發展對 ampicillin,tetracycline,kanamycin,chloramphenicol之抗藥基因。 原核的雙質體系統包括用於啟動目標基因(蛋白純化構體基因)表現的 T7啟動子。第二個質體提供一用於嚴密控制表現的>^溶菌蛋白。π RNA 聚合酶基因,在任何前述之啟動子/操縱子之組合控制下,可置於一低拷 貝數質體之中,結合入染色體或由一lambdai菌體於感染時。第二個質 體較佳者同時攜帶一個不同的基因標記(即一個不同的表現型標記)。 1304810 • 真核載體如在酵母菌表現所用者,基本上包含大腸桿菌及酵母菌各一 , 個之複製起始點,一用於兩種細胞的基因標記,及一控制酵母菌表現的 DNA調控序列的穿梭載體(shuttle vector)。該調控序列一般包括一啟 動子,一調控序列及一轉錄終止訊息(包括一polyadenylati〇n訊息)。亦 可選擇插入指導細胞分泌的訊息序列至此真核載體中。 . 典型可併入之正向筛選標記包括提供需用於製造尿嘧啶(uracil),白 胺酸(leucine),組胺酸(histidine),腺嘌呤(adenine),色胺酸及其他 φ 相似品的基因突變互補標記。併入真核載體中較佳的啟動子序列,包含 酒精去氫酶I或II型(alcohol dehydrogenase I or⑴、甘油酿構酸脫 氫酶(glyceraldehyde phosphate dehydrogenase)、磷酸甘油酸激酶 (Phosphoglycerokinase)、半乳糖、色胺酸、mating facto _a啟動 子及其他相似品。 昆蟲細胞之表現系統,包括美國專利第4745〇51號所載之BEVS系統。 ΠΙ. A· 3.微生物之轉形 用於轉移感染或轉形表現載體的微生物可以是以單細胞的原核或從哺 • 乳動物或昆蟲的細胞為基礎的真核多細胞生物體。單細胞或簡單多細胞 ' 纟物體為較佳的宿主細胞。較佳的宿主細胞包括大腸桿菌和酵母菌 ^Saccharomyces cerevisiae) ° -較佳的具體實補,如场桿8狐21⑽3) pLysS可祕雙質體 的原核表現系統。其他的大腸桿_株亦能被並發揮此表現系統的 特f生。在㈣度表現方法生產蛋白純化構體蛋自時,具有某些蛋白酶表 見缺的酵母®為較佳的真核宿主。溫度敏感酵母突變株也是較佳的真 核宿主。 ΠΙ. B.表現步驟的實施方法Confirmed by standard DNA sequencing in Sambrook et al. A feature of the invention is that the intein' can be automatically cleaved by temperature, pH changes or stimulation of the compound. Inteins known in the art can be used in the scope of the present invention. A preferred embodiment is the intein GyrA and DnaB. A preferred cleavage reaction is initiated by stimulation with temperature, pH or compound. III. A.l c. Variable fusion polypeptide portion The third portion of the sequence consists of the nucleic acid coding sequence of the protein of interest, wherein a preferred embodiment is a single product polypeptide or a plurality of product polypeptide units. The units therein can in turn accommodate one or two product polypeptides. To prepare a single product polypeptide, a single copy of the gene is ligated to the DNA fragment selected by the above list. To prepare two copies of a product polypeptide incorporated in a plurality of units, the binding between the nucleic acid sequences of the two product polypeptides is linked by the DM sequence of the intein, and the nucleic acid sequence of the interconnected polypeptide selected between the units by the foregoing list connect them. After repeated colonization, multiple units of this gene can bind to each other. This multi-unit gene encodes a fusion polypeptide fragment encoding variable 24 1304810. HI. A. 2. Recombinant Genes Incorporate Expression Vectors Recombinant expression vectors that ultimately incorporate a protein purification construct gene are compatible with host cells. The carrier used has many features in common. These features include a replication initiation site compatible with host cells 'DNA sequences for transcriptional regulation and control of transcription (for inducible systems)' an efficient ribosome binding site (prokaryotic host), a P〇 1y_A message (eukaryotic host). In addition, this vector may also include phenotypic genes, regulatory regions and leader sequences. Prokaryotic vectors, such as E. coli, are characterized by a genetic marker (phenotype) for screening of the transformant strain and a DNA regulatory sequence for directing the expression of the target gene. The basic regulatory sequence contains a promoter (P) to initiate transcription. An operon (〇) controls transcription (on/off transition)' an effective ribosome binding site (10) s) to initiate translation, and a transcription termination message. The start and stop codons are provided by the inserted gene segment (protein purification construct). Prokaryotic vectors specifically include a suitable "eXpressi" ncassette" based on any applicable promoter/manipulation subsystem. Promoters typically contained in prokaryotic vectors include galactose, tryptophan, T7, lipoprotein, alkaline phosphatase, lambda left or right promoter or a combination of the above promoters. The galactose and tryptophan operons, as well as the temperature-sensitive lambda promoter, are also typically open/closed species that can be included in prokaryotic vectors. The phenotypic markers typically included in prokaryotic vectors include the development of resistance genes to ampicillin, tetracycline, kanamycin, chloramphenicol. The prokaryotic diplast system includes a T7 promoter for initiating expression of a gene of interest (protein purification construct gene). The second plastid provides a > lysozyme for tight control of performance. The π RNA polymerase gene, under the control of any of the aforementioned promoter/operators, can be placed in a low copy number plastid, incorporated into a chromosome or infected by a lambai cell. The second plastid preferably carries a different genetic marker (i.e., a different phenotypic marker). 1304810 • Eukaryotic vectors, such as those used in yeast performance, basically contain one copy of E. coli and yeast, a genetic origin for both cells, and a DNA regulation to control yeast performance. Sequence shuttle vector. The regulatory sequence generally includes a promoter, a regulatory sequence and a transcription termination message (including a polyadenylati〇n message). It is also possible to insert a message sequence that directs secretion of the cell into the eukaryotic vector. Typical introductory positive screening markers include the provision of uracil, leucine, histidine, adenine, tryptophan and other φ similarities. The gene mutation complements the marker. A preferred promoter sequence incorporated into a eukaryotic vector, comprising alcohol dehydrogenase I or II (1, glyceraldehyde dehydrogenase, phospho Lactose, tryptophan, mating facto _a promoter and other similar products. Insect cell expression system, including the BEVS system contained in US Patent No. 4745〇51. ΠΙ. A· 3. Microbial transformation for metastasis The microorganism capable of expressing the vector may be a prokaryotic cell of a single cell or a eukaryotic multicellular organism based on a cell of a mammal or an insect. A single cell or a simple multicellular '纟 object is a preferred host cell. Preferred host cells include E. coli and yeast Saccharomyces cerevisiae) - a preferred specific complement, such as the field rod 8 fox 21 (10) 3) pLysS secretory diploid prokaryotic expression system. Other large intestine rods can also be used to play the role of this performance system. Yeast® with some proteases is a preferred eukaryotic host when the protein is purified by the (four) degree method. Temperature sensitive yeast mutants are also preferred eukaryotic hosts. ΠΙ. B. Implementation method of performance steps

26 1304810 轉开重組筛裁選體及的構Γ是以標準的輕序步驟進行,限制酶切割、插入、連接、 跡_及分析皆载於前述之Sambr〇〇k實驗手冊。 接 Πί· Β·1重組載體的構築方法 以,構討贿㈣购,即在基本龍憎趙_切割位置 構體基因。如_,Γ 步伽細蛋白純化 酶刀、核酸插入及連接步驟皆載於前述之 Sambrook實驗手冊。 ^26 1304810 The reconstituted sieve splicing and construction are carried out in standard light-sequence steps. The restriction enzyme cleavage, insertion, ligation, trace _ and analysis are contained in the aforementioned Sambr〇〇k experimental manual.构 · · 1 1 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组 重组Such as _, Γ step gamma protein purification enzyme knives, nucleic acid insertion and ligation steps are contained in the aforementioned Sambrook laboratory manual. ^

III. B. 2多單元基因方法 輸嶋娜㈣㈣-福包括將所 有早獨的基因早位以及互連多肽之職相相接成—中間多單元基因。此 中間多單絲因接著被直接與相_含肽編碼之臟序列連接而轉移至 融合表現賴上。第二種方法包括依序將每—單觸基因單位以及互連 多肽之腿糊賴至齡表現傭上。在單—基目及腿序列被插入 後,第二組直接連接於第-㈣’以此方式重複_連接。在兩種情況 中,-個或多個產品多肽之單獨基因單位與其相對應的内纽,在所有 的單位及互連多肽序列都完成插入時,單元基因才形成。 III. B. 3轉形宿主細胞的方法 轉形的過練據雖賴i種麵’可歸域個齡。獅大腸桿菌 及線蟲細胞較佳之實施可見Sambrook實驗手冊。簡言之,大腸桿菌首先 培養生長至一疋岔度,在此時間點運用一種溶液處理以使其細胞壁或細 胞膜產生通透性。這些細胞接著與重組核酸混合。經過重組載體的吸收 和再度回復,轉形細胞繼續以選擇性培養液篩選出所欲得的特定菌落。 根據本發明的一項實施例’表現組合體(eXpressi〇ncassette)以一 穩定併入宿主細胞基因組之表現組合體形式被導入宿主細胞。顯而易見 27 ⑧ 1304810 • *亦可將絲驗合料人魅細触成為験於宿主細胞中複製及 . 2的重蝴w列的—部分’而無須將其併人宿主細胞基因組。此方法 所可見於各種載體諸如病毒或能於宿主細胞中複製及表現蛋白質的 貝體載體…特定實施例為一個揭帶一複製起始點之質體,其允許高拷 貝數如大腸㈣的Puc系質體。額外地,可改變該質體以使之包含一可誘 導啟動子,胸附f_IPTG解的u伽動子。 11B· 4細胞的培養方法 # α、敗A獅和雜4需要贿’繼續培細使蛋自純化構體之生產達 取佳置。為了充分的培養’將含單一重組選殖的菌落接種至適當量培養 液,在適量生長培養液與所需的溫度條件下培養,直至細胞濃度讀數 合需要。 ΙΠ_ B. 5分離方法 將油膜蛋白結合到廳可實現一簡易且有效率的蛋白純化顧。融合於 油膜蛋白末端的多肽不影響蛋白與廳結合的能力。糊油體蛋白^載 體或運送的方法提供-簡易之贼纽蛋自f湯卜無體或重新組成 • 的油體部分連接的雜合蛋白質可在一個單一步驟達成與大部分細胞性組 • 成物的分離(如離心或浮選法)。 IV.程序、準備及實例 以下的程序、準備及實例進一步闡明關於本發明的特定方面。唯它們 並不代表上面提出之本發明所完全涵蓋的範圍。 IV· A.合成基因程序 1.產品多肽之多肽及DNA序列 代表目標蛋白質DNA序列之寡核酸一般可使用根據S· l. Beaucage及 Μ· H. Caruthers之自動技術合成,Tet. Letters, 1981. 221, 859-62 28 1304810 或者’天然所需蛋白質的編碼DNA可應用公開於Sambrook實驗手冊的純化 技術分離。 IV· B.基因插入及轉形之程序 本發明中基因的限制酶蝴、連接、細朗娜、轉培養及溶解方 法之程序’基本上遵守本領域公開的基本方法。提供細節之文獻含前文 引述之Sambrook等著作。 在一較佳實施例中’DNA序列可以根據前文引述之Sarabr〇〇k實驗手冊之 程序接合起來。 IV. B. 1.限制酶切割程序 a.以内限制酶切割dna 一般而言,0.5至2g質體DNA於20L之1倍限制酶緩衝液中以1-20單位内 限制酶切割。該反應混合液依限制酶供應商建議於室溫下反應丨至16小 時。反應混合液接著進行凝膠電泳使依分子量分離或進一步根據前文引 述之Sambrook實驗手冊之標準程序純化DNA。 IV· B· 2.基因插入及連接之程序 一般而言’該選殖載體依前述限制酶切割程序以適當限制酶切割。線 性化載體接著可在熟悉本領域者以牛小腸驗性鱗酸酶(cal f intest ina 1 phosphatase, CIP)或細菌驗性磷酸酶(bacter i a 1 a 1 ka 1 ine phosphatase, BAP)進行去磷酸化。進一步根據前文引述之Sambrook實驗手冊之標準程 序純化該DNA,其中程序通常使用石碳酸萃取及酒精沉澱。 該待插入之DNA片段接著以3-5倍(大片段時)或20-30倍(短片段寡核酸) 過量的切割之選殖載體混合。連接反應係於1倍連接酶緩衝液(20 inM Tris pH 7. 6,10 inM MgCK 0. 4 mM beta-mercaptoethanol,0. 4-1. 〇 mM ATP), 在T4DNA連接酶存在下,在16°C反應16小時。將少量連接好之載體用於轉 29 1304810 形大腸桿菌勝任細胞及重組質體之篩選。 Ιν· B. 3.大腸桿菌之轉形程序 在一較佳實施例中,可根據本領域技術使重組質體轉形入大腸桿菌。 iV· Β· 4·酵母菌之轉形程序 現已有數項酵母菌之轉形程序。其中兩種主要被應用者為 spheroplast-及lithium方法,兩者皆引用自R〇thstein,r,DNAC1〇ning PP. 45-66,IRL Press Ltd.,〇xford (1986)。 iV· C.篩選程序 在一較佳實施例中,可以將轉形後之大腸桿菌菌落塗佈於含有適量抗 生素之選擇性培養基來篩選它們的表現形(對抗生素抗藥性)。篩選轉形 後之酵母菌細胞較佳方法則是據本領域技術’利用營養省略培養基來篩 選。其他本領域已知的篩選技術也可使用。 IV. D.培養程序 在一較佳實施例中,培養細胞方法可根據前文引述之Sambr〇〇k程序處 理。簡言之,該方法必須將單一菌落轉移至一小量(3—5 ml)含適當抗生 素細菌培養液(如Luria培養液)。將培養菌培養於37T。(或其他適當溫度 下)並放大於更大體積量。酵母菌細胞之培養情形類似,培養於3〇。(;酵母 菌營養省略培養基。 IV. E.溶解程序 所需蛋白質可用各種技術依同型合子宿主細胞特性擇其優者萃取之, 包括用水溶液、緩衝液萃取培養液及諸如磨碎、打破、研磨或其他使細 胞破裂方式。宿主細胞可被萃取(例如,以離心或將碎片沉積)為三部份: >儿澱物或不可溶沉渣、液樣上清層及一包含種子貯藏脂質之與油體之汽 浮層。這些油體包含原生性油體蛋白及嵌合(chimeric)油體蛋白,後III. B. 2 Multi-unit gene method Transmitted Na (4) (4)-Fu includes the integration of all the early genes and the inter-peptides into an intermediate multi-unit gene. This intermediate multifilament is then transferred to the fusion expression by being directly linked to the phase-containing peptide-encoded visceral sequence. The second method consists of sequentially aligning each of the one-touch gene units and the legs of the interconnected polypeptides to the performance of the age. After the single-base and leg sequences are inserted, the second group is directly connected to the -(four)' in this way to repeat the_connection. In either case, the individual gene units of the one or more product polypeptides and their corresponding internal elements are formed when all of the units and the interconnected polypeptide sequences are inserted. III. B. 3 Method of Transducing Host Cells The shape of the transformation is based on the age of the species. A better implementation of the lion E. coli and nematode cells can be found in the Sambrook Laboratory Manual. Briefly, E. coli is first grown to a degree of growth, at which point a solution is used to make the cell wall or cell membrane permeable. These cells are then mixed with the recombinant nucleic acid. Upon absorption and re-recovery of the recombinant vector, the transformed cells continue to screen for the specific colonies desired in a selective medium. An expression assembly (eXpressi〇ncassette) according to one embodiment of the invention is introduced into a host cell in the form of a performance assembly that is stably incorporated into the genome of the host cell. It is obvious that 27 8 1304810 • * can also be used as a part of the sputum in the host cell and not in the human host cell genome. This method can be found in a variety of vectors such as viruses or shellfish vectors capable of replicating and expressing proteins in host cells. A particular embodiment is a plastid that uncovers the origin of replication, which allows for high copy numbers such as Puc of the large intestine (4). Systematic body. Additionally, the plastid can be altered to include an inducible promoter, a gamma tract attached to the f_IPTG solution. 11B·4 cell culture method #α, 败A狮和杂4 need to bribe. Continue to train to make the egg from the purification structure to achieve good quality. For adequate culture, colonies containing a single recombinant selection are inoculated to an appropriate amount of culture medium, and cultured in an appropriate amount of growth medium under the desired temperature conditions until the cell concentration reading is required. ΙΠ _ B. 5 Separation method Combining oil film proteins into the hall enables a simple and efficient protein purification. Polypeptides fused to the ends of oil film proteins do not affect the ability of the protein to bind to the hall. The paste oil protein carrier or transport method provides - the simple thief New Zealand egg from the f soup body in vivo or reconstituted • The oil body part of the hybrid protein can be achieved in a single step with most of the cell group Separation of matter (such as centrifugation or flotation). IV. PROGRAM, PREPARATION, AND EXAMPLES The following procedures, preparations, and examples further clarify certain aspects of the invention. They do not represent the scope of the invention as set forth above. IV. A. Synthetic gene program 1. Polypeptide of DNA of product polypeptide and DNA sequence The oligonucleic acid representing the DNA sequence of the target protein can generally be synthesized according to the automatic technology of S. l. Beaucage and H. Caruthers, Tet. Letters, 1981. 221, 859-62 28 1304810 or the DNA encoding the 'naturally desired protein can be isolated using the purification techniques disclosed in the Sambrook Laboratory Manual. IV. B. Procedure for gene insertion and transformation The procedures for restriction enzymes, ligation, spinach, transfer culture and dissolution methods of the genes in the present invention 'substantially comply with the basic methods disclosed in the art. The literature providing details includes the work of Sambrook et al. cited above. In a preferred embodiment, the DNA sequence can be joined according to the procedures of the Sarabruk experiment manual cited above. IV. B. 1. Restriction enzyme cleavage procedure a. Intra-restriction enzyme cleavage of dna In general, 0.5 to 2 g of plastid DNA is cleaved with restriction enzymes in 1-20 units in 20 L of 1 restriction enzyme buffer. The reaction mixture was reacted at room temperature for up to 16 hours as recommended by the restriction enzyme supplier. The reaction mixture is then subjected to gel electrophoresis to separate the molecular weight or further purify the DNA according to the standard procedure of the Sambrook Laboratory Manual, cited above. IV·B· 2. Procedure for gene insertion and ligation Generally, the selection vector is subjected to the restriction enzyme cleavage procedure described above to appropriately limit enzymatic cleavage. The linearized vector can then be dephosphorylated by cal f intest ina 1 phosphatase (CIP) or bacteri ia 1 a 1 ka 1 ine phosphatase (BAP). Chemical. The DNA was further purified according to the standard procedure of the Sambrook Laboratory Manual cited above, wherein the procedure was usually performed using a rock carbonic acid extraction and alcohol precipitation. The DNA fragment to be inserted is then mixed with a 3-5-fold (large fragment) or 20-30-fold (short fragment oligo) over-cutting selection vector. The ligation reaction was carried out in 1 ligase buffer (20 inM Tris pH 7. 6,10 inM MgCK 0.4 mM beta-mercaptoethanol, 0. 4-1. 〇mM ATP) in the presence of T4 DNA ligase at 16 The reaction was carried out at ° C for 16 hours. A small number of ligated vectors were used to screen for competent cells and recombinant plastids of E. coli 29 1304810. Ιν·B. 3. Transformation procedure for E. coli In a preferred embodiment, recombinant plastids can be transformed into E. coli according to the art. iV· Β·4· Yeast transformation procedure There are several yeast transformation procedures. Two of the main applications are the spheroplast- and lithium methods, both of which are cited by R〇thstein, r, DNA C1〇ning PP. 45-66, IRL Press Ltd., 〇xford (1986). iV·C. Screening Procedure In a preferred embodiment, the transformed E. coli colonies can be applied to a selective medium containing an appropriate amount of antibiotic to screen their expression (antibiotic resistance). A preferred method of screening for transformed yeast cells is by means of the art using a nutrient omitting medium for screening. Other screening techniques known in the art can also be used. IV. D. Culture Procedure In a preferred embodiment, the method of culturing cells can be processed according to the Sambr〇〇k procedure cited above. In short, the method must transfer a single colony to a small amount (3-5 ml) of a culture medium containing the appropriate antibiotic (such as Luria broth). The culture was cultured at 37T. (or other suitable temperature) and zoom in on a larger volume. The culture of the yeast cells was similar and cultured at 3〇. (; yeast nutrition omitting medium. IV. E. The protein required for the lysis procedure can be extracted by various techniques depending on the characteristics of the zygote host cell, including extracting the culture solution with an aqueous solution, a buffer solution, and grinding, breaking, grinding, etc. Or other means of rupturing the cells. The host cells can be extracted (for example, by centrifugation or deposition of debris) into three parts: > granules or insoluble sediments, liquid supernatants, and a seed-containing lipid The vapor layer of the oil body. These oil bodies contain the native oil body protein and the chimeric oil body protein.

30 1304810 , 者包含欲純化的產品多肽。 IV. F.基於油體蛋白的分離程序及準備 在培養後,所需蛋白質如以下方式純化:在離心後,因為油性雜物可 浮於表層,在油體表面與油體蛋白融合之所需蛋白質可輕易地與其他细 胞萃取物分開。再度懸浮的油體可直接以目標蛋白_固定相加以利 肖,或在設計接合?序壯以溫度或化學品料麟需蛋自雜蛋白油 體部分分開。 ' • 在本發明中,若一接合子包含内含肽,則將此懸浮緩衝液以特定的溫 度或化學品處理,此步驟將所需多肽釋出於水層。第二次離心步驟則將 使處理過的油體漂浮於溶液上層,留下釋出多肽或所需蛋白質於水層。 釋出之多肽或所需蛋白質可依其性質或應用上需求或許以沉殿、化學性 改變或冷珠乾燥。 IV. G·最後分離程序 在所需蛋白質被以溫度或化學品從結合油體蛋白上裂解後,組成物之 分離可應用本領域公知技術達成。 _ 從重組油體釋出之所需蛋白質可高純度地用一次以上離心後於上清液 .«^(VanRooijenG.J.H. and Moloney Μ. Μ. 1995. Biotechnology. 13: 72-77.)。 因此,發明者發明了-基於細菌表現與油體技術,可功能性的表達並 &化蛋白質的新方法。發明者並以納豆麟(natt〇ki咖&的表現與功能 也月此新方摘功效。在此方法巾,綠目標蛋白以不可溶的油膜蛋白 融合多肽形式過度表現,輕易的以離心方式自細胞溶解中的碎片沈積中 回收’重組入Α0Β並以内含肽的自我裂解功能自A〇B中分離出來,最後再 以離心最終上、絲的方式濃舰獲得目標蛋自。她於過去侧娜系統30 1304810, which contains the product polypeptide to be purified. IV. F. Oil protein-based separation procedure and preparation After culture, the desired protein is purified as follows: after centrifugation, because oily impurities can float on the surface, it is required to fuse with oil body protein on the surface of the oil body. Proteins can be easily separated from other cell extracts. Can the resuspended oil body be directly attached to the target protein_stationary phase, or designed to be joined? The order is separated by temperature or chemical material. In the present invention, if a zygote comprises an intein, the suspension buffer is treated with a specific temperature or chemical, and this step releases the desired polypeptide out of the aqueous layer. The second centrifugation step will float the treated oil body to the upper layer of the solution, leaving the released polypeptide or the desired protein in the aqueous layer. The released polypeptide or desired protein may be dried, chemically altered or dried by cold beads depending on its nature or application. IV. G. Final Separation Procedure After the desired protein is cleaved from the bound oil body protein by temperature or chemical, separation of the composition can be accomplished using techniques well known in the art. _ The desired protein released from the recombinant oil body can be centrifuged more than once in high purity in the supernatant. «^(VanRooijenG.J.H. and Moloney Μ. Μ. 1995. Biotechnology. 13: 72-77.). Therefore, the inventors have invented a new method for functional expression and & protein based on bacterial expression and oil body technology. The inventor also used Natto Lin (natt〇ki coffee & performance and function also this new party extract effect. In this method towel, green target protein in the form of insoluble oil film protein fusion polypeptide over-expression, easily by centrifugation Recycling from the debris deposition in cell lysis 'recombination into the Α0Β and separating the self-cleavage function of the intein from A〇B, and finally obtaining the target egg by centrifuging the final, silky way. She is on the past side Na system

31 1304810 必須使用昂貴的蛋白酶進行特定的切割(Peng,c. c.,et al,^31 1304810 Explosive proteases must be used for specific cleavage (Peng, c. c., et al, ^

Biotechnology 2GG4, 111,51-57),本方法利用溫度、pH值的調整或化 學品二硫蘇糖醇(dithiothreitol,DTT)的刺激來啟動内含肽的自我裂 解’可顯著崎低操作成本。任-目標蛋自可與賴蛋白的氮端或碳端 融合,皆可達到約3〇〇 mg/L的產量與6〇%左右的回收率。因此,使用者可 選用任融合方案,端視目標蛋白既有的限制而定。报顯然的,這個系 統提供一簡易且便宜的蛋白質表現與純化方法。 以下實施例並非完全表示本發明所能涵蓋之完全範圍。更進一步言, 本發明亦可贿麟其他實施枝。在此舉丨例證解釋本㈣在此說明 書所及的申請範圍。 【實施方式】 實例1質體之構築 本實例中所使用進行PCR的寡核酸列於表二。發明者在數個步驟之中建 構最終載體P0SP1與p〇SP2,這兩個載體分別具有在氮端與碳端與油膜蛋 白連接的内含肽。將載體pET-265(Wang,z. w.,etal, lacI. Bi(ytechn〇1.Biotechnology 2GG4, 111, 51-57), the method utilizes temperature, pH adjustment or stimulation of the chemical dithiothreitol (DTT) to initiate self-cleavage of the intein, which can significantly reduce operating costs. The arbitrarily-targeted egg can be fused with the nitrogen or carbon end of the lysin, and can achieve a yield of about 3 〇〇 mg/L and a recovery of about 6%. Therefore, the user can choose any fusion protocol depending on the limitations of the target protein. Obviously, this system provides a simple and inexpensive method of protein expression and purification. The following examples are not intended to be exhaustive of the full scope of the invention. Furthermore, the present invention may also be used for other implementations. This is an illustration of the scope of the application in this book. [Embodiment] Construction of plastid of Example 1 The oligonucleic acid used for PCR in this example is shown in Table 2. The inventors constructed the final vectors P0SP1 and p〇SP2 in several steps, each having an intein linked to the oil membrane protein at the nitrogen end and the carbon end, respectively. The vector pET-265 (Wang, z. w., et al, lacI. Bi (ytechn〇1.

Prog. 2004,20, 1352-1358)利用引子CH015與CH016增幅成含有T7啟動 子與laclts (將Gly265以lacl的Asp替換)的DNA片段。利用引子CH017與 CH018,自載體PPL450 (Love,C. A·,etal,Escherichia coli. Gene 1996’ 176,49-53)產生含有bla基因的DM。其後的兩個pcr DMA的接合 產生了載體PWIN20。類似PWIN20,將載體pET29a (Novagen,ffl)以限制 酶Xhol-Mlul切割,並以同樣的限制酶切割的pWIN2〇片段接合,因此產生 了含有載體pET29a的多重選殖位(muitipie ci〇ning site)的載體pj〇i。 為了獲得油膜蛋白,發明者利用引子〇le8與〇〗e9來增幅載體pET29〇ie (Peng, C. C., et al, J. Agric. Food Chem. 2004, 52, 3115-3119)Prog. 2004, 20, 1352-1358) Amplification of the DNA fragment containing the T7 promoter and laclts (replacement of Gly265 with Asp of lacl) using primers CH015 and CH016. Using the primers CH017 and CH018, DM containing the bla gene was generated from the vector PPL450 (Love, C. A., et al, Escherichia coli. Gene 1996' 176, 49-53). Subsequent bonding of the two pcr DMAs produced the vector PWIN20. Similar to PWIN20, the vector pET29a (Novagen, ffl) was cleaved with the restriction enzyme Xhol-Mlul and ligated with the same restriction enzyme-cleaved pWIN2(R) fragment, thus producing a muitipie ci〇ning site containing the vector pET29a. The vector pj〇i. In order to obtain the oil film protein, the inventors used the primers 8le8 and 〇e9 to increase the vector pET29〇ie (Peng, C. C., et al, J. Agric. Food Chem. 2004, 52, 3115-3119)

32 1304810 中的油膜蛋白基因。將獲得DM再次選殖入載體pj〇i的Nc〇i-BamHi位置以 產生載體pJOl-〇le4。再以引子Ssp2與Ssp3自載體pTWINl (New England BioLabs,ΜΑ)產生含有内含肽Ssp DnaB的PCR DNA。再將由PCR增幅的 DNA與pJOl-ole4以EcoRI-Sall限制酶切割,再連接後成為載體p〇spl。 類似的,將以引子Jo7與Jo8產生的油膜蛋白次選殖入pj〇i的位Oil film protein gene in 32 1304810. The DM was again re-selected into the Nc〇i-BamHi position of the vector pj〇i to generate the vector pJOl-〇le4. PCR DNA containing the intein Ssp DnaB was generated from the vector pTWIN1 (New England BioLabs, ΜΑ) using the primers Ssp2 and Ssp3. The PCR-amplified DNA was cleaved with pJOl-ole4 with EcoRI-Sall restriction enzyme and ligated to form vector p〇spl. Similarly, the oil film proteins produced by the primers Jo7 and Jo8 are sub-selected into the position of pj〇i.

置以產生載體pJ01-〇le2。同樣將載體pj〇i-〇ie2與含有内含肽Mxe GyrA 的DNA以限制酶Notl與Hindlll切割,再接合成為載體p〇sp2。這個含有内 含肽的DNA則是來自用引子Mxe2與j〇6增幅載體pTWINl所得。 表二。本實例g用的引子列表 弓I子編Sfe 序列木 CH015 TGCAGGCCTACAGGGCGCfiTCCCΑΤΤΓ (/T Ί CH016 GATCCTGCAGCCTAATGAGTGAGCTAAC (Pstl) CH017 TCGAGGCCTGCGAGCTTGG (Stul) CH018 CGCTCTGCAGCTTCCTCGomrTi; r 〜n CH0112 TGCGGAAnCGCGGAAAAAGCAGTACAG (ΕηΗϋλ Ί Jo6 GACCGCGGCCGCCAGTAGCGTG f射ΙΊ Jo7 TCGGGCGGCCGCAAATGGCTGAGCAnATG (Ά^ίΤΊ Jo8 AGAMCTCGAGTAAAGAAGTTTGAGAC () Hxe2 GCGAATTAAGCTTGGGCTCTTCCTGC (Hindi 11) 01e8 TCTTAGATCTAATGGTGAGCATTATGGTC {BgllI) 01e9 TGAGCCATGGCAACAGGCTGCTGCTGCGAG (Ncol) RC0310 TAGAGTCGACTAAnGTGCAGCTGCTTGTAC (Sail) RC0325 ACATGAATTCGCGCAAATCTGTTCC (EccRl) RC0436 CCATAGATCTGGCCGGAAAAAGCAG (賴 I) RC0437 AGGTGAATTCTTTGTGCAGCTGCTTG (ifccRI) Ssp2 GGTCCCATGGTGCGCGAGTCC {Ncol) 33 1304810Set to generate vector pJ01-〇le2. Similarly, the vector pj〇i-〇ie2 and the DNA containing the intein Mxe GyrA were cleaved with restriction enzymes Notl and Hindlll, and ligated into the vector p〇sp2. This intein-containing DNA was obtained from the primer vector Mxe2 and the j〇6 amplification vector pTWIN. Table II. This list of primers used in example g bow I promoter sequence coding Sfe wood CH015 TGCAGGCCTACAGGGCGCfiTCCCΑΤΤΓ (/ T Ί CH016 GATCCTGCAGCCTAATGAGTGAGCTAAC (Pstl) CH017 TCGAGGCCTGCGAGCTTGG (Stul) CH018 CGCTCTGCAGCTTCCTCGomrTi; r ~n CH0112 TGCGGAAnCGCGGAAAAAGCAGTACAG (ΕηΗϋλ Ί Jo6 GACCGCGGCCGCCAGTAGCGTG f exit ΙΊ Jo7 TCGGGCGGCCGCAAATGGCTGAGCAnATG (Ά ^ ίΤΊ Jo8 AGAMCTCGAGTAAAGAAGTTTGAGAC () Hxe2 GCGAATTAAGCTTGGGCTCTTCCTGC (Hindi 11) 01e8 TCTTAGATCTAATGGTGAGCATTATGGTC {BgllI) 01e9 TGAGCCATGGCAACAGGCTGCTGCTGCGAG (Ncol) RC0310 TAGAGTCGACTAAnGTGCAGCTGCTTGTAC (Sail) RC0325 ACATGAATTCGCGCAAATCTGTTCC (EccRl) RC0436 CCATAGATCTGGCCGGAAAAAGCAG (Lai I) RC0437 AGGTGAATTCTTTGTGCAGCTGCTTG (ifccRI) Ssp2 GGTCCCATGGTGCGCGAGTCC {Ncol) 33 1304810

SsP3 GCCGGATCCGGCTCTTCCGTTGTG (方aa/HI) *引入的限制酶位置以括號表示,並以底線標示於序列下方。 • 發明者再利用兩組引子對CH0112-RC0310與RC0436-RC0437以PCR自 載體pTrc-proNAT (Y. P· Chao)合成帶有能轉錄納豆激酶基因與其前 驅多肽(propeptide)、前納豆激酶(pronattokinase)的DNA。再以限制 - 酶EcoRI_Sa11或Bglll-EcoRI處理,將所得的PCR產物接合至p〇SPl _ 與p0SP2指定的限制酶切位,分別產生載體pNATl與pNAT2。為了產生 類似pNATl,但沒有攜帶前驅多肽納豆激酶基因的載體pMT3,發明者將 pOSPl與經由引子阢〇31 〇與RC0325增幅的納豆激酶基因增幅片段接合。 以類似的步驟,發明者將這個PCR片段中以載體pTrc-proNAT内的前納 豆激酶基因替換成為載體pTrc-NAT。 實例二培養方法 發明者將指定的載體轉形入大腸桿菌菌株腿(腦)(N〇vagene)並 _ ⑷几青黴素(ampicillin)藥性篩選。將獅的細胞在—a—⑹她⑽) - 培養液中培養,並且使用分光光度計(獅,Jasco)以吸光值550議 γι)來測定細胞生長密度。為表現重組蛋白,準備過夜的培養液並 分別置入新鮮的培養射。將細胞培養液轉在37γ,直到細胞密度達 到0D咖值〇. 5時,以100 μΜ IPTG誘導啟動蛋白生產。在4小時的誘導 之後’以離心收集細胞,並以!虬的〇. 〇1 M磷酸納緩衝液(邱5)再 懸浮細胞以利之後續的檢測。 八重組納讀酶或是其前驅蛋白,亦即帶有—先導祕肽義豆激酶, /刀別在大腸桿菌中在trc啟動子的控制與IpTG的誘導下表現(圖—)。 34 1304810 • 表現的納豆激酶(28 kDa)或前納豆激酶(37 kDa)主要出現在細胞溶 解後的不可溶部分(圖―)。如此產生賴豆激酶或是前納豆激酶並沒有 • 任何的酵素活性。 實例二準備人工油艘(Aob)與蛋白質復性 Α0Β系統係三酸甘油酯,磷脂與油膜蛋白_半胱胺酸蛋白質之雜合多肽 組成。a〇B依照已揭示方式準備(Peng,c· c.,etal,Bi〇techn〇i.apr〇g. 2003,19,1623-1626)。將再懸浮於lmL雜納緩衝液中的細胞(達到 鲁 OD55。值10) #Frenchpress打破’接著以離心分離成上清液與沈積碎片。 AOBs係於1 mL的10 mM璘酸鈉緩衝液(pH 7 5)中,加入15呢三酸甘油 酯(自Leader Price Co.,TW取得的菜籽油(canola)中分離而得),15〇 弘g鱗月曰,及含550/zg油膜蛋白-雜合多肽大腸桿菌碎片沉澱層所組成。 將混合物以超音波在強度3〇%下處理2〇秒。隨後將A〇B用離心收回並以緩 衝液沖洗。為獲得目標蛋白,將A0B以指定的溫度處理或以4〇 μΜ DTT處 理16個鐘頭。最後,以離心分離油層與水層,並以SDS_pAGE或是酵素活 性檢定分析在水層或在油層中的蛋白質。 φ 實例四蛋白質分析方法 發明者以領域中已知之SDS-PAGE方法(peng,c. C.,etal, J. Biotechnol· 2004,111,51-57)分析蛋白質。納豆激酶的活性檢測方 法是先加入蛋白質樣本0.01 mL至反應液0.9虬中,反應液為〇 5% caseins在0.1 Μ磷酸納緩衝液(pH 7_ 5)中。將酵素反映在37 °C下進行 5分鐘再加入0.1 raL 2N HC1停止反應。離心之後,回收上清液並在275 nm 下測量。酵素活性的一個CU定義為每分鐘每mL所產生的2叫〇1酪胺酸 (tyrosine) ° 實例五利用A0B系統表達與純化納豆激梅 35 1304810 為了功能性表達與純化,發明者先將納豆激酶(NK)或前納豆激酶 (proNK)以經由内含肽物DnaB (内含肽幻連接到油膜蛋白的碳端的 形式’在大腸桿菌中過度表現(圖一)。這兩個過度表現的蛋白,亦即油 膜蛋白-内含肽S-Μ或油膜蛋白-内含肽s_pr〇NK,皆主要發現於離心後的 不溶層中(圖三八’四八)。Α0Β主要由不溶的碎片沈積,其中主要包含膜 蛋白-内含肽S-NK或油膜蛋白-内含肽S-pr〇NK所組成。在離心後,形 成-乳狀的『浮逢』漂浮於上,而上清液(sup_2)則相對透明而幾乎不 含有碎片沈積(ppt-2)。膜蛋白—内含肽S_NK或油膜蛋白_内含肽 S-proNK,以及其他的不溶細菌蛋白,主要都出現在A〇B層(圖三B,四幻。 廷些Α0Β極穩定且可保持其結構數天,類似文獻中由TAG,pL與其他與油 膜蛋白融合的蛋白所組成的AOB (Peng,C. C.,etal,J· Biotechnol. 2〇〇4,111,51-57, Peng, C. C·,etal,J. Agric. Food Chem. 2004, 52,3115_3119)。利用將溫度由4°C提高至37 X,内含肽可自我裂解, 並將AOB中的納豆激酶或前納豆激酶釋出。隨後離心,發現成熟的納豆激 酶在兩種表現方案中都主要在上清液(sup-3)中出現,而油膜蛋白-内 含肽S則主要出現在aob中(圖三c,四c)。前納豆激酶的前導先驅多肽似 乎在與油膜蛋白-内含肽S分離之後便自動裂解。濃縮最後的上清液可得 到咼產量的可溶納豆激酶。SsP3 GCCGGATCCGGCTCTTCCGTTGTG (square aa/HI) * The position of the introduced restriction enzyme is indicated by parentheses and is indicated by the bottom line below the sequence. • The inventors used two sets of primers to synthesize CH0112-RC0310 and RC0436-RC0437 with PCR from vector pTrc-proNAT (Y. P. Chao) to synthesize a nattokinase gene with its propeptide and pronattokinase. ) DNA. The resulting PCR product was ligated to the p限制SP1 _ and p0SP2 designated restriction enzyme cleavage by restriction enzyme-Enzyme EcoRI_Sa11 or Bglll-EcoRI to generate vectors pNAT1 and pNAT2, respectively. To generate a vector pMT3 similar to pNAT1 but carrying the precursor polypeptide nattokinase gene, the inventors ligated pOSP1 to a nattokinase gene amplification fragment amplified by primer 阢〇31〇 and RC0325. In a similar procedure, the inventors replaced the pro-nattokinase gene in the vector pTrc-proNAT with the vector pTrc-NAT in this PCR fragment. Example 2 Culture Method The inventors transformed the designated vector into the E. coli strain leg (brain) (N〇vagene) and _ (4) penicillin (medicinal screening). The cells of the lion were cultured in -a-(6) her (10)-culture medium, and the cell growth density was measured using a spectrophotometer (Lion, Jasco) with an absorbance of 550 γ. To express the recombinant protein, overnight cultures were prepared and freshly cultured. The cell culture medium was transferred to 37 γ until the cell density reached 0 D coffee value 〇. 5, and starter protein production was induced with 100 μΜ IPTG. After 4 hours of induction, collect the cells by centrifugation and take!虬 〇. 〇 1 M sodium phosphate buffer (Qiu 5) resuspend the cells for subsequent detection. Eight recombination nano-reading enzymes or their precursor proteins, that is, with the leader peptide, nattokinase, were expressed in E. coli under the control of the trc promoter and IpTG induction (Fig.). 34 1304810 • The performance of nattokinase (28 kDa) or pre-nattokinase (37 kDa) occurs mainly in the insoluble fraction after cell lysis (Fig.). This produces lysin kinase or pre-nattokinase without any enzyme activity. Example 2 Preparation of artificial oil tank (Aob) and protein renaturation The Α0Β system is composed of triglyceride, a hybrid peptide of phospholipid and oil membrane protein-cysteine protein. a〇B was prepared in the manner disclosed (Peng, c. c., et al, Bi〇techn〇i. apr〇g. 2003, 19, 1623-1626). The cells in the 1 mL of the nano-buffer buffer were resuspended (to reach Lu OD55. Value 10) #Frenchpress Breaking' and then separated into supernatants and sediment fragments by centrifugation. AOBs were added to 1 mL of 10 mM sodium citrate buffer (pH 7 5), and 15 triglycerides (separated from rapecane oil obtained from Leader Price Co., TW), 15 〇Hongg 鳞月曰, and consists of a 550/zg oil film protein-hybrid polypeptide E. coli fragment precipitation layer. The mixture was treated with ultrasound at a strength of 3 〇% for 2 sec. A〇B was then withdrawn by centrifugation and rinsed with buffer. To obtain the target protein, A0B was treated at the specified temperature or treated with 4 〇 μΜ DTT for 16 hours. Finally, the oil and water layers are separated by centrifugation and analyzed for protein in the aqueous layer or in the oil layer by SDS_pAGE or enzyme activity assay. φ Example Four Protein Analysis Method The inventors analyzed proteins by the SDS-PAGE method known in the art (peng, c. C., et al, J. Biotechnol. 2004, 111, 51-57). The method for detecting the activity of nattokinase is to first add 0.01 mL of the protein sample to 0.9 反应 of the reaction solution, and the reaction solution is 〇 5% caseins in 0.1 Μ sodium phosphate buffer (pH 7_ 5). The enzyme was reacted at 37 ° C for 5 minutes and then 0.1 raL 2N HCl was added to stop the reaction. After centrifugation, the supernatant was recovered and measured at 275 nm. One CU of enzyme activity is defined as 2 tyrosine (tyrosine) produced per minute per mL. Example 5 Expression and purification of natto citrate 35 1304810 using A0B system For functional expression and purification, the inventor first introduced natto Kinase (NK) or pre-nattokinase (proNK) is overexpressed in E. coli via the intein DnaB (intein linked to the carbon-terminal form of oil film protein) (Figure 1). These two overexpressed proteins , that is, the oil film protein-intein S-Μ or the oil film protein-intein s_pr〇NK, are mainly found in the insoluble layer after centrifugation (Fig. 38 '48). Α0Β is mainly deposited by insoluble fragments. It mainly consists of membrane protein-intein S-NK or oil membrane protein-intein S-pr〇NK. After centrifugation, a milk-like "floating" floats on top, while supernatant (sup_2) ) is relatively transparent and contains almost no debris deposition (ppt-2). Membrane protein-intein S_NK or oil film protein_intein S-proNK, and other insoluble bacterial proteins, mainly appear in the A〇B layer ( Figure 3B, four illusions. Ting some Α 0 Β extremely stable and can maintain its number of structures ABOB consisting of TAG, pL and other proteins fused to oil film proteins in similar literature (Peng, CC, et al, J. Biotechnol. 2〇〇4, 111, 51-57, Peng, C. C., etal , J. Agric. Food Chem. 2004, 52, 3115_3119). Using an increase in temperature from 4 ° C to 37 X, the intein can self-cleave and release nattokinase or pre-nattokinase in AOB. It was found that the mature nattokinase appeared mainly in the supernatant (sup-3) in both performance schemes, while the oil membrane protein-intein S mainly appeared in the aob (Fig. 3c, c). The leading precursor polypeptide of nattokinase appears to be cleaved automatically after separation from the oil film protein-intein S. The final supernatant is concentrated to obtain a soluble nattokinase produced by hydrazine.

實例六產量與表現納豆激酶的最佳pH 為得到最佳的純化方法,發明者測試了在不同pH值情況下的純化產 量。在兩種表現方案中(利用與膜蛋白-内含肽S-NK或與油膜蛋白-内含 狀S-proNK融合)’在pH 7-9的蛋白產量是類似的(圖五A)。重組納豆激 酶在低於pH6的產量則未測量,因為A0B在酸性條件傾向聚集,可能是因 為表面的電負性互斥作用因中和而削弱。基於酪蛋白(casein)較佳的水 36 ^04810 解性,自油膜蛋白-内含肽S-proNK釋放的表現的納豆激酶其專一活性較 自’由骐蛋白-内含肽S-NK釋放的高五倍之多(圖五b)。納豆激酶的生產的 最佳條件,為在pH 7.5,以Α0Β表現/純化系統利用油膜蛋白—内含肽 s~Pr〇NK作為重組載體。一如預期,在重組納豆激酶中可測到血纖維蛋白 溶解活性(fibrinolytic activity)(圖六)。 實例七以内含肽ifreGyrA連接到油膜蛋白氮端的前納豆激酶 為了測試利用Α0Β表現純化系統,可否將目標蛋白融合在油膜蛋白的氮 端,發明者將前納豆激酶以另一個連接子,内含肽^狀办以(内含肽^^, 其可以化合物DTT刺激自我裂解,與油膜蛋白融合(圖一)。此重組蛋白 質依前述與油膜蛋白碳端融合的同樣方法過度表現、收回、融入與自a〇b 釋放(圖七)。同樣地’成熟的納豆激酶可自最終上清液中收回,而前導 前驅多肽亦已自動裂解了。發明者婦了自廳職的重_豆激酶在 4、25與37 X下的產量(圖八A)。發明者發現在37 %可得到相當有效率 的產量,並在此溫度下職不同PH值對產f的影^發明者發現依此方 案,最佳的重組納豆激酶的表現方案是在pH 7.5時(圖八B,八c)。 實例八目標蛋白之回收 因此’發明者發明了-基於細菌表現與油體技術,可功能性的表達並 純化蛋白質的新方I發明者並以納豆激酶的表現與功能證明此新方法 的功效。在此方法中,紐目標蛋白以不可溶的油膜蛋白融合多狀形式 過度表現,輕易的以離心方式自細胞溶解中的碎片沈積中回收,重組入 Α0Β後再以内含肽的自我裂解功能自娜中分離出來,最後以離心最終 上清液的方式濃縮並獲得目標蛋白(圖九)。發明者並發現任-目標蛋白 不論與賴蛋㈣氮端或碳端融合,皆可達到約· _的產量與6〇% 左右的回收率。Example 6 Yield and Performance Optimum pH for Nattokinase To obtain the best purification method, the inventors tested the purified yield at different pH values. Protein yields at pH 7-9 were similar in both performance protocols (using fusion with membrane protein-intein S-NK or with oil membrane protein-containing S-proNK) (Figure 5A). The yield of recombinant natto kinase at pH below 6 was not measured because A0B tends to aggregate under acidic conditions, probably because the surface electronegativity is weakened by neutralization. Based on the better casein water 36 ^04810 cleavage, the nattokinase expressed from the oil film protein-intein S-proNK is more specific than the release from the prion-intein S-NK. Five times higher (Figure 5b). The optimal conditions for the production of nattokinase are as follows: at pH 7.5, the oil membrane protein-intein s~Pr〇NK is used as a recombinant vector in the Α0Β performance/purification system. As expected, fibrinolytic activity was detected in recombinant nattokinase (Figure 6). Example 7 Pre-nattokinase linked to the N-terminus of the oil membrane protein with the integrose ifreGyrA. To test the purification system using the Α0Β expression, can the target protein be fused to the nitrogen end of the oil membrane protein, the inventor will use the former nattokinase as another linker, intein The inclusion of peptide (^, which can stimulate self-cleavage by compound DTT, and fusion with oil film proteins (Fig. 1). This recombinant protein overexpresses, retracts, integrates and self-expresses in the same way as the oil membrane protein carbon end fusion described above. A〇b release (Figure 7). Similarly, 'mature nattokinase can be recovered from the final supernatant, and the precursor precursor polypeptide has been automatically cleaved. The inventor has a heavy weight of _ Bean kinase in the office. The yields at 25 and 37 X (Fig. 8A). The inventors found that at 37%, a fairly efficient yield was obtained, and at this temperature, different pH values were produced for the production of f. The inventors found that according to this scheme, the most The performance of the recombinant nattokinase is at pH 7.5 (Fig. 8B, VIIIc). Example 8 Recovery of the target protein was therefore invented by the inventor - based on bacterial expression and oil body technology, functional expression The inventors of the purified protein I have demonstrated the efficacy of this new method with the performance and function of nattokinase. In this method, the target protein is overexpressed in the form of insoluble oil membrane protein fusion polymorphism, easily by centrifugation. The debris was deposited in the cell lysis, recombined into Α0Β, and then separated by the self-cleavage function of the intein, and finally concentrated by centrifugation of the final supernatant to obtain the target protein (Fig. 9). The inventor also found - The target protein can achieve a yield of about _ _ and a recovery of about 6% regardless of whether it is fused with the nitrogen or carbon end of the lyophilized egg.

37 1^04810 , 【圖式簡單說明】 ,目,-卡棚齡所有本發日稽例咖_融合蛋自。納豆激酶、 前驅多肽、油膜蛋白、内含肽s、内含肽M的相對位置以及他們的分子 量皆顯示於每一重組多肽的圖上。 B 一係在大勝才干菌中表現的納豆激酶與前納豆激酶的娜一 p顧圖。 在有或沒有IPTG的誘導下’發明者將所有大腸桿菌表現的(a)納豆激 眷 81與⑻前納豆激酶萃取、分離成上清液(卿―n與沈積層(卯⑷ 之中,並以SDS-PAGE檢驗。納豆激酶(28 kDa)與前納豆激酶(37 _ 的位置紐標示出來。分子量的標記包括(116㈣, bovine serum albumin (66.2 kDa) > ovalbumin (45 kDa) ^ lactate dehydrogenase (35 kDa) ’ 限制酶 Bsp981 (25 kDa)與 yS-latoglobulin (18.4 kDa)。 圖三係分析在大腸桿菌中表現的油膜蛋白-内含肽S-NK。( A)所有含 ® 有油膜蛋白-内含肽S-NK的大腸桿菌皆被萃取、分離至上清液(sup-i)37 1^04810, [Simple description of the schema], the purpose, - the card shed all the hair of the day. The relative positions of nattokinase, precursor polypeptide, oil membrane protein, intein s, intein M and their molecular weights are shown on the map of each recombinant polypeptide. B. A series of nattokinase and pre-nattokinase that are expressed in the bacterium. Induction by the inventors with or without the induction of IPTG, (a) natto, 81 and (8) pre-nattokinase were extracted and separated into supernatants (qing-n and sedimentary layers (卯(4), and SDS-PAGE assay. Nattokinase (28 kDa) and pre-nattokinase (37 _ position markers are indicated. Molecular weight markers include (116 (d), bovine serum albumin (66.2 kDa) > ovalbumin (45 kDa) ^ lactate dehydrogenase ( 35 kDa) 'Restriction enzymes Bsp981 (25 kDa) and yS-latoglobulin (18.4 kDa) Figure 3. Analysis of the oil film protein-intein S-NK expressed in E. coli. (A) All oil-containing membrane proteins containing - Escherichia coli containing the peptide S-NK was extracted and separated into supernatant (sup-i)

與沈積層(ppt-1)之中。並以SDS-PAGE分析。(Β)Α0Β與沈積層(ppt-1) 和含有油膜蛋白-内含肽S_NK的大腸桿菌的溶解細胞重組。重組後,在 10’000 g,15分鐘的離心後,產生了三個分層,上清層(sup_2),沈積 層(PPt-2)與A0B。以SDS-PAGE分析這三層。(C)將溫度自4提高到 25X以刺激與a〇b重組的油膜蛋白_内含肽s-NK的自我裂解。再以離心 方式分離成油層(裂解的A0B)與上清液(sup-3)。兩者皆以SDS-PAGE 38 1304810 分析之。納豆激酶(28 kDa)與油膜蛋白-内含肽S-ΝΚ (63 kDa)的位 置皆被標示出來。 圖四係分析在大腸桿菌中過度表現的油膜蛋白—内含肽s_pr〇NK。(A) 所有含有油膜蛋白-内含肽§_ρΓ〇ΝΚ的大腸桿菌皆被粹取、分離至上清 液(sup-1)與沈積層(ρρ1>1)之中。並以SDS_pAGE分析。A〇B 與沈積層(ppt-1)和含有油膜蛋白—内含肽s_pr〇NK的大腸桿菌的溶解 細胞重組。重組後,在10,麵g,15分鐘的離心後,產生了三個分層, 上清層(sup-2),沈積層(ppt—2)與A0B。以SDS-PAGE分析這三層。(C) 將溫度自4提高到25T以刺激與Α0Β重組的油膜蛋白-内含肽s-pr〇NK 的自我裂解。再以離心方式分離成油層(裂解的A〇B)與上清液(3111)_3)。 兩者皆以SDS-PAGE分析之。納豆激酶(28 kDa)與油膜蛋白-内含肽 S-proNK (72 kDa)的位置皆被標示出來。 圖五係在不同pH下利用a〇B產生的納豆激酶。自與油膜蛋白-内含狀 S-NK (〇)油膜蛋白_内含肽s_pr〇NK (·)重組的廳獲得的納豆激酶的 (A)產量與(B)相對專一活性分別在pH 7到9之間測量。 圖六係自Α0Β生產的納豆激酶的血纖維蛋白溶解活性(fibrin〇ly1:ic activity)。將一滴雞血凝結置於一瓊酯凝膠上,再以水(控制組)或獲 得的納豆激酶處理’測量caseionlytic的活性。在室溫下觀測4小 時血凝集的水解。 圖七係分析大腸桿菌中過度表現的pr〇NK-内含肽M一油膜蛋白。(a)With the deposited layer (ppt-1). And analyzed by SDS-PAGE. (Β) Α0Β Recombined with lysed cells of the deposited layer (ppt-1) and Escherichia coli containing the oil film protein-intein S_NK. After reconstitution, after 10'000 g, 15 minutes of centrifugation, three layers, a supernatant layer (sup_2), a deposition layer (PPt-2) and A0B were produced. The three layers were analyzed by SDS-PAGE. (C) Increasing the temperature from 4 to 25X to stimulate self-cleavage of the oil membrane protein_intein s-NK recombined with a〇b. The oil layer (cleaved A0B) and the supernatant (sup-3) were separated by centrifugation. Both were analyzed by SDS-PAGE 38 1304810. The positions of nattokinase (28 kDa) and the oil film protein-intein S-ΝΚ (63 kDa) were identified. Figure 4 is an analysis of the oil film protein-intein s_pr〇NK, which is overexpressed in E. coli. (A) All E. coli containing the oil film protein-intein §_ρΓ〇ΝΚ were extracted and separated into the supernatant (sup-1) and the sediment layer (ρρ1 > 1). And analyzed by SDS_pAGE. A〇B recombines with the lysed cells of the deposited layer (ppt-1) and Escherichia coli containing the oil film protein-intein s_pr〇NK. After reconstitution, after 10, g, 15 minutes of centrifugation, three layers, a supernatant layer (sup-2), a sediment layer (ppt-2) and A0B were produced. The three layers were analyzed by SDS-PAGE. (C) Increasing the temperature from 4 to 25T to stimulate self-cleavage of the oil membrane protein-intein s-pr〇NK recombined with Α0Β. The oil layer (cracked A〇B) and the supernatant (3111)_3) were separated by centrifugation. Both were analyzed by SDS-PAGE. The positions of nattokinase (28 kDa) and the oil film protein-intein S-proNK (72 kDa) were identified. Figure 5 shows nattokinase produced by a〇B at different pHs. The (A) yield and (B) relative specific activity of nattokinase obtained from the recombination of oil film protein-containing S-NK (〇) oil membrane protein_intein s_pr〇NK (·) at pH 7 respectively Between 9 measurements. Figure 6 is a fibrinolytic activity (fibrin〇ly1:ic activity) of nattokinase produced from Α0Β. A drop of chicken blood was coagulated on a agarate gel and the caseinlytic activity was measured by treatment with water (control group) or obtained nattokinase. The hydrolysis of blood agglutination was observed for 4 hours at room temperature. Figure VII is an analysis of the overexpressed pr〇NK-intein M-oil membrane protein in E. coli. (a)

39 1304810 所有含有ΡΠΜ-内含肽M_崎㈣大腸膽被粹取、分離至上清液 (聲1)與沈積層(ppt-丨)之中。並以sds_page分析。⑻與沈 積層(PPt-υ和含有师_含肽料縣_大麟_溶解細胞 重組。重組後,在1M〇Gg,15分鐘的離心後,產生了三個分層,上清 層(sup-2),沈積層(ppt_2)與娜。以齡刪分析這三層。⑹ 加入DTT以刺激與廳重組的pr〇NJ^含肽M油膜蛋白的自我裂解。再 以離心方式分離成油層(裂解的)與上清液⑽―3)。兩者皆以 SDS PAGE刀析之。納豆激酶(28咖)與ρΐΌΝΚ_内含肽M_油膜蛋白(π kDa)的位置皆被標示出來。 圖八係自與proNK-内含肽M-油膜蛋白重組的A0B產生納豆激酶。(a ) 分別在4,25與37 °C測量與pr〇NK-内含肽Μ-油膜蛋白重組的A0B產生 的納丑激酶的產量(pH 7. 5)。在pH 7到9之刺量這個重組納豆激酶 的(B)產量與(C)相對專一活性。 圖九係Α0Β表現/純化系統的示意圖。步驟1 (以阿拉伯數字顯示): 在大腸桿菌中過度表現目標蛋白,該蛋白為一不溶性的融合油膜蛋白。 步驟2 : Α0Β與不溶的油膜蛋白—内含肽融合蛋白的組成。步驟3 :以離 心收集Α0Β。步驟4 :透過溫度改變或加入DTT將目標蛋白自結合於Α0Β 的油膜蛋-内含肽融合蛋白分離。步驟5 :收集離心後在最終上清液中的 目標蛋白。39 1304810 All of the large intestines containing the ΡΠΜ-intein M_崎(四) were extracted and separated into the supernatant (sound 1) and the deposited layer (ppt-丨). And analyzed by sds_page. (8) Recombination with the deposited layer (PPt-υ and containing the _ peptide-containing county _ Dalin _ lysed cells. After reconstitution, after centrifugation at 1 M 〇Gg, after 15 minutes of centrifugation, three layers were formed, the supernatant layer (sup -2), sedimentary layer (ppt_2) and Na. The three layers were analyzed by age. (6) DTT was added to stimulate the self-cleavage of the pr〇NJ^-containing peptide M oil membrane protein recombined with the hall, and then separated into oil layers by centrifugation. Cleaved) with supernatant (10) -3). Both are analyzed by SDS PAGE. The positions of nattokinase (28 ca) and ρΐΌΝΚ_intein M_oil membrane protein (π kDa) are indicated. Figure VIII shows the production of nattokinase from A0B recombined with the proNK-intein M-oil membrane protein. (a) The production of ugly kinase (pH 7.5) produced by A0B recombined with pr〇NK-intein Μ-oil membrane protein was measured at 4, 25 and 37 °C, respectively. The recombinant nattokinase (B) yield and (C) relative specific activity at pH 7 to 9. Figure 9 is a schematic representation of the Β0Β performance/purification system. Step 1 (shown in Arabic numerals): Excessive expression of the target protein in E. coli, an insoluble fusion membrane protein. Step 2: Composition of Α0Β with an insoluble oil film protein-intein fusion protein. Step 3: Collect Α0Β by centrifugation. Step 4: Separation of the target protein from the oil-membrane egg-intein fusion protein bound to Α0Β by temperature change or addition of DTT. Step 5: Collect the target protein in the final supernatant after centrifugation.

Claims (1)

1304810 公告本 *· ___ . . . I . n. I, I I 1U__ _ 〜 • δ月U曰修(i)正本 « 十、申請專利範圍:L---- 1· 一種多肽,係包括: a. —結合油體之油膜蛋白質〔〇le〇sin〕;及 b. —内含肽(intein)胺基酸片段,其係連接至油膜蛋白質 〔oleosin〕,此内含肽為 vifre GyrA 或 6!sp DnaB。 2. 根據申請專利範圍第1項之多肽,其另包含一目標多肽,該多肽連 接至内含狀。 3. 根據申請專利範圍第1項之多肽,其係利用酵母菌或細菌宿主細胞 生產。 S 4. 根據申請專利範圍第1項之多肽,其係利用大腸桿菌生產。 5. 根據申請專利範圍第丨項之多肽,其中内含肽之自我剪接反應功能 可用化合物、溫度或pH值改變誘導啟動。 6_根據申請專利範圍第2項之多肽,其中目標多肽係單一產品肽或單 零 -產品肽之多重複製品。 7. 根據中請專利範圍第2項之多肽’其中目標多肽與該多狀之前狀 (propeptide)以操作性方向連接。 8. 根據申請專概_ 7項之多肽,其愤肽與目標多肽皆可直接與 内含肽連接。 ~ 9·根據中請專利範圍第2項之多肽,其中目標多狀係指納豆激酶 (nattokinase) ° 41 1304810 .钃 J 10.根據申請專利範圍第5項之多肽,其中化合物係指二硫蘇糖醇 (dithiothreitol, DTT)。 11. 根據申請專利範圍第5項之多肽,其中溫度係指〇。(:至5〇°C。 12. 根據申請專利範圍第11項之多肽,其中溫度係指4°c至37°C。 13. 根據申請專利範圍第12項之多肽,其中溫度係指25°C至37°C。 14. 根據申請專利範圍第13項之多肽,其中溫度係指37。(:。 • 15.根據申請專利範圍第5項之多肽,其中pH值係指PH 6, 5至pH 9. 5。 16.根據申請專利範圍第15項之多肽,其中PH值係指pH 7至邱9。 17根據申請專利範圍第16項之多肽,其中pH值係指pH 7. 5。 18_根據申請專利範圍第1項之多肽,其中油膜蛋白質係來自於植物。 19.根據申請專利範圍第1項之多肽,其中油膜蛋白質係來自菜籽油 (canola oil)。 % 20_ —種混合物,包含申請專利範圍第丨項之多肽及用於和此多肽中結 合油體肽結合之油體。 21. 根據申請專利範圍第2〇項之混合物,係用於純化目標多肽。 22. 根據申請專利範圍第2〇項之混合物,其中油體係從植物中提煉。 23_根據申請專利範圍第2〇項之混合物,其中油體係從菜籽油(can〇la oil)中提煉。 42 1304810 24根據申請專利範圍第2〇項之混合物,其中油體為人工合成。 25_根據申請專利範圍第20項之混合物,其中油體係由三酸甘油脂與 填脂組成。 26_根據申請專利範圍第25項之混合物’其中油體中三酸甘油脂與碟 脂之比例為100 : 1至1 : 100。1304810 Announcement** ___ . . . I. n. I, II 1U__ _ ~ • δ月曰U曰修(i)本本« X. Patent Application: L---- 1· A polypeptide, including: a - a combination of oil film protein [〇le〇sin]; and b. - intein amino acid fragment, which is linked to the oil membrane protein [oleosin], the intein is vifre GyrA or 6! Sp DnaB. 2. The polypeptide of claim 1, further comprising a polypeptide of interest, the polypeptide being linked to the inclusion. 3. A polypeptide according to claim 1 of the patent application, which is produced using yeast or bacterial host cells. S 4. The polypeptide according to claim 1 of the patent application, which is produced by using Escherichia coli. 5. A polypeptide according to the scope of the patent application, wherein the self-splicing reaction function of the intein can be initiated by a change in the compound, temperature or pH. 6) The polypeptide according to item 2 of the patent application, wherein the target polypeptide is a single product peptide or a multi-repetition product of a single zero-product peptide. 7. The polypeptide according to item 2 of the scope of the patent application wherein the polypeptide of interest is linked to the propeptide in an operative direction. 8. According to the peptides of the application, the peptidomimetic and the target polypeptide can be directly linked to the intein. The polypeptide according to the second aspect of the patent application, wherein the target polymorphism refers to nattokinase ° 41 1304810 . 钃 J 10. The polypeptide according to claim 5, wherein the compound refers to dithiosu Dithiothreitol (DTT). 11. A polypeptide according to claim 5, wherein the temperature is 〇. (: to 5 ° ° C. 12. The polypeptide according to claim 11 wherein the temperature means 4 ° C to 37 ° C. 13. The polypeptide according to claim 12, wherein the temperature means 25 ° C to 37 ° C. 14. The polypeptide according to claim 13 wherein the temperature means 37. (: 15. The polypeptide according to claim 5, wherein the pH means PH 6, 5 to The polypeptide according to the fifteenth aspect of the patent application, wherein the pH value refers to pH 7 to Qiu 9. The polypeptide according to item 16 of the patent application, wherein the pH value means pH 7.5. The polypeptide according to the first aspect of the invention, wherein the oil film protein is derived from a plant. The polypeptide according to claim 1, wherein the oil film protein is from a canola oil. The polypeptide comprising the scope of the patent application and the oil body for binding to the oil body peptide in the polypeptide. 21. The mixture according to the second aspect of the patent application is used for purifying the target polypeptide. a mixture of the second item, wherein the oil system is extracted from the plant 23_ A mixture according to the scope of claim 2, wherein the oil system is extracted from canola oil. 42 1304810 24 A mixture according to the scope of claim 2, wherein the oil body is synthetic 25_ According to the scope of claim 20, wherein the oil system consists of triglyceride and fat. 26_The mixture according to claim 25 of the patent application' wherein the triglyceride and the disc grease in the oil body The ratio is 100: 1 to 1: 100. 27·根據申請專利範園第26項之混合物,其中油體中三酸甘油脂與鱗 脂之比例為5〇 : 1至1 : 50。 28·根據申請專利範圍第26項之混合物,其中油體中三酸甘油脂與鱗 脂之比例為1〇〇 : 1。 29·根據申請專利範圍第2〇項及第25項之混合物,其中油體中之鱗脂 與多肽之比例為1 : 10至1〇 : 1。 30·根據申請專利範圍第29項之混合物’其中油體中之磷脂與多狀之 比例為1 : 4至4 : 1。 31·根據申請專利範圍第30項之混合物,其中油體中之鱗脂與多狀之 比例為1: 4。 32.—種純化目標多肽之方法,包括以下步驟: a.製備多肽,其包含: i. 一結合油體之油膜蛋白質〔oleosin〕; ii. 一内含肽〔intein〕胺基酸片段’其係連接至油膜蛋白質 43 1304810 〔oleosin〕,此内含肽為GyrA或岛ο DnaB ;及 iii. 一目標多肽,該多肽連接至内含肽; b_混合多狀與油體,而產生油體混合物; c. 將油體混合物從其餘細胞萃取物之碎片分離; d. 將目標多肽從結合油體部分切割;及 e. 將目標多肽從其餘油體混合物分離。 33_根據申凊專利範圍第32項之方法,其中内含肽之自我前接反映功 能可用化合物、溫度或pH值改變誘導啟動。 34. 根據申請專利範圍第32項之方法,其中目標多肽係單一產品肽或 單一產品肽之多重複製品。 35. 根據申請專利範圍第32項之方法,其中步驟b之混合物可使用超 音波震盪產生。 36. 根據申請專利範圍第32項之方法,其中步驟c之分離可用離心處 理。 37. 根據申請專利範圍第32項之方法,其中步驟e之目標多肽可用離 心將其與油體混合物之剩餘物中分離。 44 Ϊ304810圖五 -/6ε) SS 2 500050005027. According to the mixture of the application for patent No. 26, the ratio of triglyceride to scale in the oil body is 5〇: 1 to 1: 50. 28. A mixture according to claim 26, wherein the ratio of triglyceride to scale in the oil body is 1 : 1 . 29. A mixture of the second and fifth items of the patent application, wherein the ratio of the scale to the polypeptide in the oil body is 1:10 to 1 :1. 30. The mixture according to claim 29 of the patent application wherein the ratio of the phospholipid to the polymorphism in the oil body is 1:4 to 4:1. 31. A mixture according to claim 30, wherein the ratio of scale to polymorphism in the oil body is 1:4. 32. A method for purifying a polypeptide of interest, comprising the steps of: a. preparing a polypeptide comprising: i. an oil film protein [oleosin] in combination with an oil body; ii. an intein amino acid fragment Is linked to oil film protein 43 1304810 [oleosin], the intein is GyrA or island ο DnaB; and iii. a target polypeptide, the polypeptide is linked to the intein; b_ mixed polymorphism and oil body, resulting in oil body a mixture; c. separating the oil body mixture from the fragments of the remaining cell extract; d. cleavage of the polypeptide of interest from the bound oil body; and e. separating the polypeptide of interest from the remaining oil body mixture. 33_ The method according to claim 32, wherein the self-introduction function of the intein is initiated by a change in the compound, temperature or pH. 34. The method of claim 32, wherein the polypeptide of interest is a single product peptide or a multiple repeat of a single product peptide. 35. The method of claim 32, wherein the mixture of step b is produced using ultrasonic oscillation. 36. The method of claim 32, wherein the separating of step c is performed by centrifugation. 37. The method according to claim 32, wherein the target polypeptide of step e is separated from the remainder of the oil body mixture by centrifugation. 44 Ϊ304810图五-/6ε) SS 2 5000500050 ο ·°Η 8 ρ ·5 ο ο ο ο ο ο 0 8 6 4 2 1 (次)逛谀丨蛉叙萆ο ·°Η 8 ρ ·5 ο ο ο ο ο ο 0 8 6 4 2 1 (次) 谀丨蛉 谀丨蛉 萆 8· ΡΗ 3 Ί3048108· ΡΗ 3 Ί304810 55
TW94136100A 2005-10-17 2005-10-17 Oil body-based purification of proteins TWI304810B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94136100A TWI304810B (en) 2005-10-17 2005-10-17 Oil body-based purification of proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94136100A TWI304810B (en) 2005-10-17 2005-10-17 Oil body-based purification of proteins

Publications (2)

Publication Number Publication Date
TW200716663A TW200716663A (en) 2007-05-01
TWI304810B true TWI304810B (en) 2009-01-01

Family

ID=45071023

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94136100A TWI304810B (en) 2005-10-17 2005-10-17 Oil body-based purification of proteins

Country Status (1)

Country Link
TW (1) TWI304810B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115074340B (en) * 2022-06-17 2023-02-28 广州市乾相生物科技有限公司 Novel intein and application thereof in synthesis of human tropoelastin

Also Published As

Publication number Publication date
TW200716663A (en) 2007-05-01

Similar Documents

Publication Publication Date Title
JP3129437B2 (en) Purification-directed cloning of peptides
Song et al. Cultivation at 6–10 C is an effective strategy to overcome the insolubility of recombinant proteins in Escherichia coli
JP2008509682A (en) Protein production method using YEBF
JP3878207B2 (en) Expression plasmid controlled by osmB promoter
CZ284204B6 (en) Peptide, nucleic acid molecule, vector, prokaryotic host cell and process for preparing nfg polypeptide
JPS60137286A (en) Superoxide dismutase gene
Engel et al. Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase
TW505697B (en) Method for cleavage of fusion proteins
Pang et al. Expression and characterization of recombinant human lactoferrin in edible alga Chlamydomonas reinhardtii
JP2008193953A (en) Development and application of new protein expression system using actinomyces as host
US5552302A (en) Methods and compositions for production of human recombinant placental ribonuclease inhibitor
TWI304810B (en) Oil body-based purification of proteins
JP2007520200A (en) Protein expression system
CN101955969A (en) Construction and application for general efficient and soluble pronucleus fusion expression vector
JP4937570B2 (en) Protein production method using fish
EP0422217B1 (en) Human recombinant placental ribonuclease inhibitor and method of production
JP5177431B2 (en) Method for manufacturing TRACP5b
Wahlroos et al. Increase of histidine content in Brassica rapa subsp. oleifera by over-expression of histidine-rich fusion proteins
JPH03219891A (en) Expression of functional insect-specific poisonous gene in mammalian cell
JPH06503718A (en) Production of human lysothyme and its efficient secretion in methylotrophic yeast cells
Dracheva et al. Expression of Soluble Human Interleukin-2 Receptor α-Chain inEscherichia coli
Zhou-Chou et al. Expression, purification and characterisation of secreted recombinant glycoprotein PsA in Dictyostelium discoideum
Ubeidat et al. Expression and one-step purification of a developmentally regulated protein from Dictyostelium discoideum
WO2009054754A1 (en) PHINS21 RECOMBINANT PLASMID FOR ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN, AN Escherichia coli JM109/pHINS21 BACTERIA STRAIN AS A PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN AND A HUMAN PROINSULIN PRODUCING METHOD
EP2684960A1 (en) Expression vector for a secretion and detection system

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees